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Resumo 
Os investigadores de cenas de crime enviam, frequentemente, para os Laboratórios 
forenses amostras biológicas limitadas em quantidade e qualidade do ADN, devido a 
condições ambientais, tempo e condições de preservação. Para facilitar a análise destas 
amostras, a InnoGenomics Technologies desenvolveu novos kits para quantificação e 
amplificação de ADN (InnoQuant® HY and InnoTyper® 21) baseados em 
retrotransposões. O objetivo do presente trabalho foi validar internamente os kits 
InnoQuant® HY e InnoTyper® 21, sob as condições de trabalho do Laboratório de Polícia 
Científica da Polícia Judiciária (LPC-PJ) e avaliar a sua capacidade para produzir 
resultados em amostras recolhidas em cenas de crime reais. 
Para a validação interna foram realizados testes de sensibilidade, repetibilidade e 
reprodutibilidade. Adicionalmente, foi também realizado um estudo de concordância 
entre os kits atualmente em uso no LPC-PJ e estes novos kits. Para os testes 
anteriormente descritos foram selecionadas 132 amostras de extratos do LPC-PJ 
(principalmente cabelo com folículo, mas também sangue, vestígios de contacto e 
dentes). Finalmente, foi analisado um conjunto de 40 amostras de cabelo sem raiz para 
observar a capacidade dos kits InnoQuant® HY e InnoTyper® 21 para produzir resultados 
nestas amostras consideradas difíceis do ponto de vista forense. 
Os resultados obtidos para os testes de sensibilidade, repetibilidade e reprodutibilidade 
permitiram validar internamente os kits InnoQuant® HY and InnoTyper® 21. Das 132 
amostras testadas, os resultados demonstraram que o kit InnoQuant® HY foi capaz de 
produzir resultados de quantificação em cerca de 28,8 % mais das amostras analisadas 
do que o kit the Quantifiler® Duo, indicando o novo kit é mais efetivo no tratamento de 
amostras difíceis. No que respeita ao kit InnoTyper® 21, os resultados demonstraram 
que no conjunto de amostras selecionadas e sob as condições de trabalho utilizadas 
neste estudo, as diferenças observadas entre ambos os kits (InnoTyper® 21 e 
GlobalFiler™) não foram significativas. Contudo, foi comprovada a utilidade do kit 
InnoTyper® 21, especialmente devido a amplificação de um grande número de perfis 
genéticos completos. Os resultados obtidos para o conjunto de 40 amostras de cabelos 
sem raiz permitiram confirmar que ambos os kits InnoQuant® HY e InnoTyper® 21 
representam boas alternativas para análise de amostras difíceis. 
Keywords: Retrotransposões, InnoQuant® HY, Indice de Degradatção, InnoTyper® 21, 
INNULs  
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Abstract 
Forensic laboratories frequently receive, from crime scene investigators, biologic 
samples that are limited regarding DNA quantity and quality, due to environmental 
stresses, storage time and preservation conditions. In an attempt to facilitate the analysis 
of this type of biological samples, InnoGenomics Technologies developed new 
commercial DNA quantification and amplification kits (InnoQuant® HY and InnoTyper® 
21) which use retrotransposons as molecular markers. The aim of this work was to 
perform the internal validation of InnoQuant® HY and InnoTyper® 21 kits, under the 
working conditions of the Laboratório de Polícia Científica da Polícia Judiciária (LPC-PJ) 
and to evaluate the ability of these kits for obtaining results with samples taken from real 
crime scenes. 
For the internal validation, sensitivity, repeatability, and reproducibility tests were 
performed. A concordance study between the kits currently in use at LPC-PJ (Quantifiler® 
Duo and GlobalFiler™) and these new retrotransposon-based kits was also performed. 
Therefore, 132 samples were selected from extracts of LPC-PJ caseworks (mainly hairs 
with follicle but also blood, contact traces, and teeth). Additionally, a set of 40 rootless 
hair samples was analyzed to observe the ability of InnoQuant® HY and InnoTyper® 21 
kits to produce results with these challenging samples. 
The results obtained for sensitivity, repeatability, and reproducibility tests allowed 
internally validated both InnoQuant® HY and InnoTyper® 21 kits. For the 132 samples 
tested, results demonstrate that InnoQuant® HY kit was able to produce quantification 
results in nearly 28.8 % more of the analyzed samples than the Quantifiler® Duo kit, 
indicating that the new kit is more effective in treating challenging samples. Regarding 
the InnoTyper® 21 kit, results demonstrate that for the samples selected and under the 
conditions used in this study, the differences observed between the kits (InnoTyper® 21 
and GlobalFiler™) were not significant. Therefore, the utility of InnoTyper® 21 has been 
proven, especially by the successful amplification of a greater number of complete 
genetic profiles. The results obtained for the set of 40 rootless hair samples allowed to 
confirm that both InnoQuant® HY and InnoTyper® 21 kits represent very good alternatives 
for the analysis of challenging samples. 
Keywords: Retrotransposons, InnoQuant® HY, Degradation Index, InnoTyper® 21, 
INNULs  
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1. Introduction 
Forensic Genetics deals with the application of genetic knowledge to resolve legal cases. 
In a crime scene, two major types of evidence can be obtained. Testimonial evidence is 
obtained by a statement from people who may have witnessed the crime or part of it. 
Physical evidence is something left at the crime scene that can take several forms and 
dimensions, being able to prove that the crime was committed or establish a key element 
of a crime. Amongst physical evidence, the direct evidence supports a fact without 
inference; while the circumstantial evidence compels an inference to associate the 
evidence to the conclusion of a fact. Thus, the interpretation and use of physical evidence 
becomes critical in forensic research [1, 2]. 
In the recent years, the use of deoxyribonucleic acid (DNA) as forensic evidence gained 
importance in forensic investigations. The use of DNA evidence has rapidly increased 
and considerably benefited justice due to the recent developments in the field of DNA 
testing [3]. Evidence collected in casework and processed at forensic laboratories 
enables to establish a probability-based connection between a crime scene, particular 
individuals (either suspects or victims), and objects involved in a crime. Such link, 
determined by the comparison of the genetic profiles, complemented by other means of 
proof, is often critical to assist in acquitting or convicting the suspect [3, 4].  
Aims 
The main aims of the present work were to internally validate both InnoQuant® HY and 
InnoTyper® 21 kits (InnoGenomics Technologies) for later implementation in Laboratório 
de Polícia Cientifíca da Polícia Judiciária (LPC-PJ) routine laboratory, and to evaluate 
the ability of these new retrotransposons-based kits to produce results in challenging 
samples. Thus, the genetic profiles from challenging samples (hairs, contact traces, 
blood, and teeth) obtained from crimes scenes and suspects using conventional 
approaches (Quantifiler® Duo and GlobalFilerTM, Thermo Fisher Scientific) were 
compared with the results obtained using these new retrotransposons-based kits. 
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1.1. Historical contextualization of Forensic Genetics 
Over the years, several techniques have been developed to resolve legal conflicts or 
criminal cases. Early in the 20th century, Karl Landsteiner described the ABO blood 
system group and found that it was possible to allocate people into four groups according 
to their blood type. This system, based on four blood groups (A, B, AB, and O), has been 
proven useful to determine if a particular donor is the contributor of a sample left at a 
crime scene [4, 5]. 
Fifteen years later, Leone Lattes reported the use of ABO typing system in resolving a 
paternity test. The first step towards the use of biological markers to distinguish between 
individuals was given [4, 5]. 
In the 1960s and 1970s, the developments of Molecular Biology techniques, such as the 
use of restriction enzymes, Sanger sequencing, and Southern blotting, allowed the 
examination of DNA sequences, having been reported in the 1980s the analysis of the 
first polymorphic locus [4]. 
In 1985, Alec Jeffreys described DNA fingerprinting (also known as DNA typing or DNA 
profile), reporting that certain DNA regions contain tandemly repeated sequences 
(variable number of tandem repeats, VNTR) and that the number of repeats differs 
amongst individuals [6]. Thus, the restriction fragment length polymorphism (RFLP) 
technique, that allows examining the variation in the size of these repetitive DNA 
sequences, has been developed for application in human identification testing. The 
RFLP consists in the DNA cleavage by restriction enzymes to produce fragments of 
variable lengths. Then, fragments are separated by size in an agarose gel 
electrophoresis being polymorphic loci detected by Southern blotting using hybridization 
probe [5, 6]. Each locus has a different number of repeats being created a distinctive 
pattern for each individual; therefore, RFLP analysis has proven to be a highly 
discriminative method. However, this technique requires large amounts of DNA (50 to 
500 ng) [4]. This limitation associated with DNA degradation in samples left at the crime 
scene which prevents the amplification of long fragments as are the VNTR and the 
difficulty of interpreting the results obtained with this method acted as a starter for the 
introduction of polymerase chain reaction (PCR). 
PCR is an automated process to be used in the laboratory and consists in the enzymatic 
amplification of a specific region of genomic DNA sequence, using specific primers [7]. 
Developed in 1984, by Kary Mullis, the PCR technique is a powerful molecular biology 
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tool that has revolutionized all areas of medical and biological science [8]. After its 
discovery, the PCR technique was quickly incorporated into the forensic analysis, being 
used for the first time in 1988 to analyze skeletal remains. As VNTRs, the mostly used 
in casework, required large amounts of DNA, PCR technology was applied to the 
analysis of VNTR loci amplifying alleles between 5-10 kilobases (kb). However, the 
existence of forensic samples which were highly degraded and consequently had low 
amounts of DNA continued to be a problem. This limitation was overcome, at the 
beginning of the 1990s, with the development, and characterization of short tandem 
repeats (STR), that showed to be simpler and shorter than VNTR and, therefore, more 
suitable for the analysis of biological samples recovered at crime scenes [5]. 
Short tandem repeats (STR), also known as microsatellites or simple sequences repeats 
(SSRs), firstly identified in the early 1980s, are tandemly repeated DNA sequences. 
Consist of repeated regions with 1-6 base pairs (bp) long (mono-, di, tri-, tetra-, penta- 
and hexanucleotide repeats) and in alleles that are shorter than 350 bp. STRs are 
distributed throughout the entire human genome being the majority located in non-coding 
regions, either in introns or intergenic sequences [4, 5, 9, 10], STRs are highly 
polymorphic in nature being important genetic markers for mapping studies, disease 
diagnosis, and human identity tests [11]. The simplicity of PCR amplification without the 
problems of differential amplification (due the fact that both alleles from a heterozygous 
individual are similar in size since the repeat size is small) associated with the possibility 
of successfully typing low amounts of DNA even in a degraded form, made STRs 
widespread for current forensic applications [11-13]. However, and even though 
thousands of polymorphic STRs have been characterized in the human genome, only a 
small set of loci were chosen for use in forensic DNA and human identity tests [14]. STRs 
can be divided into three different groups depending on their repeat structure: i) simple 
or perfect repeats have the same length and sequence in every repeat unit (e.g. 
(GATA)(GATA)); ii) compound or imperfect repeats contain stretches of two or more 
different repeat types (e.g. (GATA)(GATA)(GACA)); iii) complex or interrupted repeats 
have several blocks of repeats with different unit lengths but also contain intervening 
sequences  (e.g.:(GATA)(GACA)(CA)(CATA)) [4]. Concerning human identification, the 
most important feature is to have DNA markers that display the highest possible variation 
or a number of less polymorphic markers that can be combined to discriminate between 
samples [12]. Thus, among the various STR systems, forensic laboratories prefer tetra- 
or pentanucleotide locis, since the amount of stutters (additional peaks produced by 
amplicons that are typically one or more repeat units less in size than true allele and that 
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can complicate the interpretation of DNA profiles) produced during PCR is lower [9, 12]. 
In general, the analysis of autosomal STR is highly discriminant and sensitive. However, 
in certain cases, this analysis fails, or becomes difficult to interpret [4]. These cases 
usually occur during the analysis of challenging samples, such as severely degraded 
samples, hairs, DNA mixtures, and presence of PCR inhibitors. 
1.2. DNA analysis of challenging samples 
Forensic laboratories frequently receive, from crime scene investigators, biologic 
samples (mostly bone fragments, teeth, blood, and hairs) that are very limited in terms 
of DNA quantity and quality, mainly due to environmental stresses (which degrades DNA 
molecules by randomly breaking them into smaller pieces), storage time, and 
preservation conditions [6, 12]. In most cases, forensic geneticists are confronted with 
incomplete DNA profiles or lack of results from the analysis of the samples. This is 
because STRs, the genetic markers of choice for DNA analysis, produce long amplicon 
sizes. As DNA degradation takes place, this molecule becomes progressively more 
fragmented and difficult to amplify. Additionally, samples collected from crime scenes 
are often contaminated with PCR inhibitors, such as hematin, which interfere with PCR 
process and produce profiles with alleles and/or locus drop-out [15-17]. 
Hair shafts are one of the most common types of evidence found during crime scene 
investigation, and as such becomes an ideal sample for DNA testing. In cases where 
hair samples sent to the laboratory still containing the root, the probability of obtaining a 
complete DNA profile using the standard PCR technology is around 60% - 70%. 
However, most of the hairs found at the crime scenes are rootless. Unfortunately, the 
highest amount of DNA is located in the root. Therefore, it is expected that the analysis 
of rootless hair samples does not produce results making them a problem for forensic 
laboratories despite their great evidence value in court [18, 19]. When receiving rootless 
hair samples, genetic experts are faced with the need for special approaches to achieve 
better results. Thus, new approaches, such as mini-STRs and also the mitochondrial 
DNA have been developed [16]. However, the difficulties in obtaining profiles remain, 
and the mitochondrial DNA analysis has the disadvantage of providing a result of 
maternal lineage and not individual identification. In the recent years, an alternative 
methodology using mobile elements has been proven useful in such cases. 
1.3. Mobile elements in forensic DNA analysis 
Mobile DNA elements, also known as transposable elements (TEs) or "jumping genes", 
are genomic sequences that have the ability to move independently into different parts 
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of the genome (within and sometimes between genomes) [20, 21]. Although the primary 
source of TEs is not entirely known, it has been hypothesized that its origin occurred 
millions of years ago from viruses that have invaded the eukaryotic genome. Reasons 
that support this hypothesis are the structural and functional similarities found between 
viruses and TEs, the fact that the drugs that inhibit virus activity can also inhibit TEs, and 
that proteins involved in the inhibition of TEs within the cells also have inhibitory effects 
on viruses [22]. 
Firstly discovered in the1940s, by Barbara McClintock, in maize, the function of these 
elements has been reported in several organisms [21, 22]. After the conclusion of the 
Human Genome Project, it has been revealed that approximately half of our genome (45 
- 47%) resulting from TEs activity. However, only a small portion of these elements 
remains active. Also, it has been estimated that nearly 25% of human promoter regions, 
as well as 4% of the human exons, have TEs derived sequences [23]. In some plants, 
TEs constitute about 90% of the genome [20, 22]. Moreover, TEs have a significant 
biological importance, especially in genome evolution, gene expression, genetic 
instability, and genetic diseases [20]. These elements induce modifications into the 
genome either by his capability to "jump" to new locations, or by facilitating chromosomal 
rearrangements [23].  
According to the method used to duplicate into the genome, TEs can be grouped into 
two distinct classes: transposons (class 2 elements) and retrotransposons (class 1 
elements), as illustrated in Figure 1.1 [24, 65]. 
 
Figure 1.1 - Schematic representation of the two classes of transposable elements and their transposition method 
(Adapted from Lodish et al., 2102 [24]) 
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1.3.1. DNA transposons 
Constituting nearly 3% of the human genome, DNA transposons have the ability to move 
in the genome [21, 25]. These elements act through a cut and paste mechanism in which 
the transposon excises itself from a particular location, moves as DNA, and reintegrates 
into new genomic sites [20, 22, 23]. Despite not being currently active in the human 
genome, these elements were active during the early primate evolution [20, 21, 26]. 
Currently, transposons remain mainly active in the genome of simpler organisms, such 
as bacteria, plants, and flies, conferring the benefit of spreading antibiotic-resistance 
genes and reproduction through sexual mode [22, 25]. 
The simplest DNA transposons, known as insertion sequences (IS), are independent 
units that encode one or two enzymes necessary for transposition, and consist of a gene 
for transposase flanked by two terminal inverted repeats (TIRs) sequences [23, 27, 28] 
(Figure 1.2). These inverted sequences, apparently identical, are oriented in opposite 
directions which are characteristic of a particular IS element and define the end of the 
transposon. As such, the transposase recognizes these TIR, excises the DNA 
transposon from its original genomic location and then generates a break in another 
genomic location where subsequently reinserts the transposon (Figure 1.3 a). Upon the 
insertion of the IS element, the sequence of the host DNA is duplicated creating target 
site duplications (TSDs), which correspond to a particular characteristic for each DNA 
transposons. At the insertion site, the IS sequence is always flanked by very short direct 
repeats (DRs) [23, 27] (Figure 1.3 b). However, non-autonomous elements that do not 
encode proteins required for mobilization have been reported. These non-autonomous 
elements depend on the autonomous transposons for their mobilization [23] (Figure 1.4). 
 
Figure 1.2 - Simplest DNA transposon containing a transposase gene flanked by two inverted repeats (Adapted from 
Russell, 2002 [29]) 
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   a)         b)  
Figure 1.3 - Mobilization mechanism of Transposons. a) Transposase recognizes the terminal inverted repeats, excises 
the transposon and then,  incorporated it into a new genomic location; b) insertion of the IS element in the host DNA and 
duplication of it sequence, creating target site duplications (TSDs) (Adapted fom Levin and Moran, 2011 [30] and Russell, 
2002 [29]).  
 
Figure 1.4 - Schematic representation of a non-autonomous transposon element. TIR, terminal inverted repeats (Adapted 
from Slotkin and Martienssen, 2007 [31]) 
In addition to these "classic” types of transposons, the DNA transposons can still be 
divided into two more main subclasses. The Helitrons whose mechanism used is 
possibly related to the rolling-circle replication (Figure 1.5 a), and the Mavericks whose 
transposition mechanism is not well understood, but it is thought that possibly replicates 
using a self-encoded DNA polymerase [28] (Figure 1.5 b). 
 
Figure 1.5 - Schematic representation from subclass 2 of DNA transposons. a) Helitron: gray rectangles represent protein 
coding regions; RPA, replication protein A; Y2 HEL, YR with YY motif helicase; bond breaking represents regions that 
can contain one or more additional ORFs; b) Marverick-Polinton: gray rectangles represent protein coding regions; C-INT, 
C-integrase; ATP, packaging ATPase; CYP, cysteine protease; POLB, DNA polymerase B; bond breaking represents 
regions that can contain one or more additional ORFs; black triangles represents terminal inverted repeats (Adapted from 
Piégu et al., 2015 [32]) 
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1.3.2. Retrotransposons 
Constituting more than 40% of the human genome, retrotransposons are another class 
of TEs (class 1) that also resort to a copy-and-paste mechanism for mobilization [33-35]. 
This mobilization mechanism resorts to an RNA intermediate which is then reverse 
transcribed into a complementary DNA (cDNA) copy by a mechanism called target-
primed reverse transcription (TPRT), and then inserted into new genomics locations [25, 
26]. 
Based on the presence of a structure named long terminal repeat (LTR), 
retrotransposons can be classified into two distinct groups: LTR and Non-LTR 
retrotransposons [20, 22] (Figure 1.6). 
 
Figure 1.6 - Retrotransposons subdivision based on their structural characteristics and mobilization (Adapted from 
Ayarpadikannan and Kim, 2014 [20]) 
LTR retrotransposons, also known as human endogenous retrovirus (HERVs), constitute 
approximately 8% of the human genome [21, 36], and possess many characteristics 
similar to retroviruses, such as reverse transcriptase (RT), ribonuclease H (RH) and 
integrase (IN) genes [37]. However, normally these elements do not have a gene 
envelope or have a nonfunctional one [36]. Encoding Pro, Gag, Pol and sometimes Env-
like proteins, its insertion in the human genome dates back over 25 million years ago, 
evolving from ancient viral infections of the germline [20, 21, 38]. As mentioned above, 
the HERVs mobilization occurs through transcription by Ribonucleic acid (RNA) 
polymerase II, followed by reverse transcription and re-integration into the host genome 
[39]. Currently, the activity of HERVs is limited in humans and the active human-specific 
LTRs identified belonging to the HERV-K family [20, 21]. Evidence suggests that the long 
terminal repeats of HERVs aid in the regulation of the expression of nearby genes due 
to the capacity of regulatory sequences found into retroviral LTR can alter or inactivate 
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the expression of adjacent genes. Moreover, HERVs insertions can potentially benefit 
the host, since its insertion in a particular location of the genome can reverse a harmful 
mutation [20]. 
Non-LTR elements are retrotransposons that do not contain long terminal repeats, and 
possess a terminal poly-A tail [36]. These old genetic elements were persevered in the 
eukaryotic genomes for hundreds of millions of years [40]. Within the non-LTR category, 
retrotransposons can be further divided into three subgroups according with their 
capacity to mobilize [22, 25]: long interspersed elements (LINEs), short interspersed 
elements (SINEs) and a composite element named SVA (SINE-R/VNTR/Alu). Non-LTR 
elements, represent the major class of mobile elements in the human genome (nearly 
21% of human DNA), due its activity and are comprised of active elements such as L1, 
Alu, and SVA - which is believed that are the only three families of retrotransposons 
currently active in the human genome - and by inactive elements as such L2 and 
mammalian-wide interspersed repeats [20, 21, 34-36, 41]. 
1.3.2.1. Line-1 or L1 elements 
Long interspersed elements-1 or L1 are autonomous retrotransposons (the only active 
autonomous mobile DNA element in the human genome) that can encode the enzymatic 
machinery necessary for transposition [22, 25]. Due to the high number of copies of these 
elements, more than 500.000 copies in the human genome resulting from the continued 
mobilization activity in the last 150 million years, L1 elements are the most abundant 
retrotransposons constituting approximately 17% of the human genome [21, 25, 36]. 
However, despite the high number of copies of these elements, only 100 of them remain 
intact [20, 21]. 
A full-length L1 element (Figure 1.7) has approximately 6 kb and is composed of a 5’ 
untranslated region (UTR), containing an internal RNA polymerase II promoter, two 
open-reading frames (ORF1 and ORF2) separated by a short inter-ORF spacer, and a 
3’ UTR that contains a polyadenylation signal ending with an oligo dA rich tail of variable 
length [20, 21, 25, 34, 36]. Usually, L1s are flanked by target site duplications created by 
the retrotransposition process and vary from 7 to 30 bp in length, approximately [36]. 
Both ORFs are necessary for the occurrence of L1 retrotransposition since they code 
the necessary proteins for this to occur. ORF1 encodes an RNA-binding protein (a 40 
kDa protein known as ORF1p) that contains a coiled-coiled domain (CC), a non-
canonical RNA recognition motif (RRM) domain, and a basic C-terminal domain (CTD). 
ORF2 encodes a protein (a 150 kDa protein known as ORF2p) with endonuclease (EN) 
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and reverse-transcriptase (RT) activities. ORF2 also contains two other conserved 
domains, the Z domain (which is immediately proximal to the RT domain and mutations 
in this area can nullify reverse transcriptase activity in vitro) and cysteine-rich motif (C-
domain) of unknown function [21, 34, 36]. This is the necessary molecular machinery 
that enables the retrotransposition process to occur and is known as target-primed 
reverse transcription (TPRT) [21, 37]. 
 
Figure 1.7 - Full-length active L1 element and its constitution: two open-reading frames (ORF1 and ORF2) for autonomous 
mobilization; TSD, target site duplication; UTR, untranslated region; EN, endonuclease domain; RT, reverse transcriptase 
domain; VNTR, variable number of tandem repeats; POLY (A), oligo dA rich tail (Adapted from Mills et al., 2007 [42]). 
The retrotransposition of the human L1 begins with transcription from the internal RNA 
polymerase II promoter. After transcription, the L1 RNA is transported to the cytoplasm 
where ORF1 and ORF2 proteins undergo translation. Several genetic, biochemical, and 
phylogenetic studies demonstrate that both proteins present a strong cis-preference and, 
consequently, they preferentially associate with the L1 RNA transcript that encodes them 
to form a ribonucleoprotein (RNP) particle which is a proposed retrotransposition 
intermediate. After this, the RNP formed is transported back into the nucleus by a 
mechanism that is still understood [21, 36]. Inside the nucleus, the L1 retrotransposition 
process probably occurs by a mechanism mentioned above named target-primed 
reverse transcription during which it is thought that the L1 endonuclease breaks the first 
strand of target DNA releasing a 3' hydroxyl, which is then used as a primer for reverse 
transcription of L1 RNA by L1 reverse transcriptase, leading to the first strand of L1 
cDNA. The second strand of the target DNA is cleaved and used as a primer for the 
synthesis of the second strand by poorly understood mechanisms. The integration 
process completes retrotransposition and results in L1 structural hallmarks, including 
frequent 5' truncations, the presence of an oligo dA-rich tail at the 3' end, and variable-
length target site duplications [21, 36] (Figure 1.8). 
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Figure 1.8 - Model of L1 retrotransposition cycle. Blue circles represents ORF1, green oval represents ORF2, black 
arrows represents variable length target site duplications, blue arrow represent the integration into the genome and 
dashed arrow represents endonuclease independent retrotransposition ( Adapted from Hulme et al., 2006 [36]). 
1.3.2.2. Alu elements 
Alu elements are another type of retrotransposon, representing the family of SINEs, 
frequently called “a parasite’s parasite” due to their inability to encode for a polymerase. 
For this reason, Alu are non-autonomous elements once they need and depend on the 
enzymatic machinery of L1 elements for its retrotransposition [20]. 
Although its transposition is dependent on the L1 autonomous elements, there are more 
than one million Alu copies in the human genome, resulting from their continued 
mobilization activity over the last 65 million years, a period that coincides with the 
radiation of primates [21, 25, 43, 44]. Therefore, Alu elements are the most successful 
mobile elements in the human genome regarding copy number (comprise approximately 
10% of the human genome sequence) [20, 21, 43, 45, 46]. 
Alu elements are divided into several subfamilies that share specific positions and that 
have been activated at different time points during primate evolution. The subfamilies Y, 
Ya and Yb of Alu elements remain active in the genome, being able to produce new Alu 
insertions that are polymorphic in the human population. However, these subfamilies 
only became active at the time of divergence between the human lineage and their last 
common ancestor, the nonhuman apes. Thus, the inclusion of Alu elements is restricted 
to humans and the ancestral allele is considered to be the absence of the insertion. The 
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human genome contains about 30 distinct categories of Alu subfamilies, being the 
AluYa5 subfamilies, AluYb8 and AluYc1 the most recently inserted and the most active 
in the human lineage [20, 46-48]. 
The constant mobilization of Alu repeats in the human genome may have numerous 
consequences, such as insertional mutations, gene conversion, recombination, changes 
in gene expression, pseudogenization, structural variation, and formation of segmental 
duplications, leading to diversity and genomic instability [20, 25, 43, 46]. 
A full-length Alu element (Figure 1.9) has approximately 300 bp in length and is 
composed of a dimeric structure formed by the union of two monomers derived from 7SL 
RNA gene (first originated from 7SL RNA as a monomeric element of about 150 bp in an 
ancestor of primates and rodents which later, in primate evolution, was fused into two 
monomers and became the nearly 300 bp dimer that characterizes most active Alu 
elements nowadays), separated by an A-rich linker region (with a consensus sequence: 
A5TACA6). The 5'-region comprises the A and B boxes that are promoters of transcription 
by internal RNA polymerase III and the element ends with an 3’ oligo dA-rich tail of 
variable length [21, 25, 37]. 
 
Figure 1.9 - Full-length active Alu element and its constitution: two monomers (derived from 7SL RNA gene) separated 
by an middle A-rich linker region; A and B boxes are promoters of transcription by internal RNA polymerase III; TSD, 
target site duplication; POLY (A), oligo dA rich tail (Adapted from Mills et al., 2007 [42]). 
As mentioned above, Alu elements do not encode proteins required for its 
retrotransposition, requiring the machinery of L1 elements. Accordingly, it has been 
assumed that retrotransposition probably also occurs via TPRT. However the trans-
mobilization mechanism by L1 proteins remains undefined. Because Alu elements do 
not have RNA polymerase III termination signals, Alu transcripts extend into the 
downstream flanking sequence until the terminator (typically a run of four or more 
consecutive Ts) is reached. Thus, these RNA polymerase III-mediated Alu transcripts 
are exported to the cytoplasm and linked to SRP9/14 proteins to form RNPs stable. It 
has been postulated that these RNPs interact with ribosomes, allowing positioning Alu 
transcripts nearby of nascent L1 ORF2 protein. Nevertheless, it is unclear whether Alu 
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RNPs have access to the L1 retrotransposition machinery in the cytoplasm or in the 
nucleus, since Alu RNPs should recruit L1 ORF2 proteins in the nucleus and immediately 
perform with TPRT [21]. 
Alus constitute an important source of human variation. Several studies suggested that 
Alu elements insertions originate present/absence variants that potentially can be used 
not only as DNA markers in human population studies but also in forensic and paternity 
analyses [20, 49]. 
1.3.2.3. SVA elements 
Firstly reported in 1994, human SVA elements are composite retrotransposons with 
approximately 3,000 copies in the human genome, being 27 - 38% of these copies 
structural polymorphic and actively mobile, resulting from its continued activity over 
around 25 million years of hominid evolution [21, 25, 50].  
A full-length SVA element (Figure 1.10) has approximately 2 kilobases (kb) in length and 
presents an hexamer repeat region, an Alu-like region, a variable number of tandem 
repeats region, an HERV-K10-like region (SINE-R element was first reported as derived 
from human endogenous retrovirus HERV-K10 [50]), and a polyadenylation signal 
ending with an oligo dA-rich tail of variable length [20, 21, 25] and is flanked by TSDs 
[51, 52] [47, 48]. 
 
Figure 1.10 - Full-length active SVA element and its constitution: an hexamer repeat region; an Alu-like region; VNTR, a 
variable number of tandem repeats region: a SINE-R region; TSD, target site duplication; POLY (A), oligo dA rich tail 
(Adapted from Mills et al., 2007 [42]). 
Although it has been proposed that SVA elements are transcribed by RNA polymerase 
II, these elements do not have internal promoters and, as such it is thought that can 
focus, at least in part, on the promoter activity in the flanking regions. Thus, it can be 
assumed that SVAs are non-autonomous elements and that, as the Alu elements, 
dependent on the retrotransposition machinery of L1 elements to proliferate into the 
human genome [21, 51]. 
The ancestral SVA has its origins about 14 million years ago and then diverged into six 
subgroups (A-F) based on their sequence divergence and evolutionary time estimates. 
According to subfamily age estimates, based on nucleotide divergence, the expansion 
of the four SVA subfamilies (A, B, C and D) began before the divergence of human, 
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chimpanzee, and gorilla, while the subfamilies E and F are characteristic to the human 
lineage (Figure 1.11). Therefore, it is thought that nearly 80% of the SVA members are 
probably human-specific in origin or, in other words, their integration in the human 
genome occurred after the human - great apes’ radiation [51, 52]. 
 
Figure 1.11 - Network of SVA subfamilies (Adapted from Wang et al., 2005 [52]) 
1.3.3. Retrotransposons insertion polymorphisms as genetic markers for 
human identification 
Transposable elements have prominent influence regarding evolutionary change since 
they can impact gene expression by introducing alternative regulatory elements, exons, 
and splice junctions. Their presence, in a wide variety of genomes, is associated with 
deletions, inversions, duplications, translocations, and chromosome breaks. Together 
with recombination, independent assortment, and sexual reproduction, mutations 
caused by TEs plays a major role in creating genetic diversity [53]. 
The use of retrotransposons, particularly SINEs, as genetic markers demonstrated that 
these present some advantages over other widely used systems. SINES have proven to 
be almost ideal markers for phylogenetic and population genetic analysis, as well as for 
the application in human identity. The bi-allelic nature of retrotransposons conveys the 
technical simplicity of typing only two alleles per genetic marker instead of typing an array 
of nucleotides (which sometimes have hundreds of nucleotides in length). The existence 
of an element in several different individuals at a given locus, when there is a significant 
number of potential insertions sites for any element, demonstrates that retrotransposons 
are only identical by descent. This makes them more accurately and stable than other 
systems regardless inheritance (they have been shown to be essentially homoplasy-
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free). The ancestral state of a SINE insertion locus is known to be the absence of the 
element which makes assumptions about this aspect of analysis unnecessary. 
Additionally, retrotransposons do not produce technical artifacts due to slippage during 
PCR, and thus should reduce some of the problems associated with the interpretation of 
STR currently used [53, 54]. Lastly, a crucial advantage is the fact that retrotransposons 
have low mutation rates, making them interesting for population studies and missing 
person kindship analysis [55]. The homoplasy-free nature of retrotransposon insertions 
allowed performing several studies that applied variation in Alu insertion frequencies to 
verify the human demography and their extension, forensic identification of specific 
individuals or groups. The use of Alu and/or L1 elements as genetic markers allowed not 
only explore ancient human origins, their migrations, and group continental human 
populations but also has proven to be preponderant for forensic applications enabling 
genotyping of unknown individuals and identifying their genetic ancestry with high 
probability [53].  
1.3.3.1. InnoQuant® HY  
For forensic laboratory analyses, it is important to determine the quality and quantity of 
the human DNA extracted from the sample, since these factors allow to estimate the 
optimal range of input DNA amounts for amplification, as well as, to facilitate the choice 
of the best amplification procedure to be applied. Therefore, it is crucial that the 
quantification method to be also extremely sensitive. Real-time PCR has several 
advantages when compared with other quantification methods, such as nonnucleic acid-
based quantification methods, total genomic methods, or DNA hybridization-based 
human and higher primate-specific DNA methods [56]. 
InnoQuant® HY kit is a real-time PCR system (qPCR) that allows evaluating both the 
quantity and quality of human DNA existing on biological samples from forensic 
caseworks. This system was developed to detect total human and male DNA, and uses 
two independent genomic targets, a multi-copy sequence of short length and a separate 
multi-copy sequence of long length, to qualitatively measure the degree of degradation 
of a sample. The degradation level of a certain sample, designated as Degradation Index 
(DI), is given by the ratio between the amount of a short strand of amplified DNA with the 
amount of a long strand of amplified DNA target, allowing to know the quality of DNA and 
thus select the best typing method [57-59]. 
For the development of this multiplex, two independent retrotransposons targets (short 
and long targets), a 79 bp male specific target and a 172 bp amplicon from a synthetic 
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template as Internal Positive Control (IPC) to assess PCR inhibition were used to design 
the primers and the TaqMan probes. The “Short” target is an 80 bp sequence from an 
Alu element (more precisely an Yb8 Alu, which lineage is the second largest young group 
of Alu subfamilies and contains nearly 1800 copies per genome) while the “Long” target 
is a 207 bp sequence from an SVA element (which contains an average of nearly 1700-
1800 copies per genome) (Figure 1.12) [57-60].  
 
Figure 1.12 - Representation of two independent retrotransposons (Alu and SVA) genomic targets; TSD, target site 
duplication (Adapted from Pineda et al., 2014 [57, 59]). 
When compared with commonly other quantification methods, the Alu systems present 
the advantage of using a large number of fixed insertions. Since they have a high copy 
number into the human genome, these tests have a high sensitivity dynamic range and 
can be successful used to quantify the human DNA in biological samples in forensic 
caseworks. The same is verified with the SVA elements which, while there are smaller 
families, contains nearly 1800 copies per genome. Thus, this large copy numbers will 
permit to minimize the effect of variation among individuals producing highly reproducible 
quantification values [57]. 
Previous studies using Ya5 Alu elements to assess the quantity of degraded DNA in 
forensic samples demonstrated a lack of reproducibility and/or sensitivity and did not 
present high PCR efficiencies [57]. These low PCR efficiencies occurred due to the 
competition between the two amplified fragments, mainly because the two Ya5 Alu 
element fragment sequences targeted were not independent [57]. To overcome this 
difficulty, this multiplex system uses two multi-copy independent targets. The inclusion 
of a sensitive Y-chromosome specific male target allows to determine accurately the 
amount of male DNA in challenging male-female mixtures (i.e. sexual assault samples) 
and easily identify when the sample processing should be terminated, modified or if the 
sample should be preserved for alternative amplification methods, such as InnoTyper® 
21 [57, 58, 60]. The inclusion of an IPC target in the multiplex allows measuring the 
FCUP 
Evaluation and validation of retrotransposons-based kits for DNA analysis of degraded biological evidence and rootless 
hair 
- 17 - 
 
 
inhibition and, in some cases, indicates potential mechanisms of inhibition in forensic 
samples [56]. 
1.3.3.2. InnoTyper® 21  
STR amplification systems are preferably used for human identification tests because 
they are highly polymorphic and provide a high degree of sensitivity [55, 61]. Thus, these 
systems allow samples containing as little as 250 pg of DNA can be typed. However, as 
already mentioned the vast majority of samples sent for analysis in forensic laboratories 
are degraded and have significantly reduced amounts of DNA. To outwit this problem, 
several authors have proven the potential of dimorphic Alu elements in cell lines 
identification, paternity testing, and forensic analysis [55]. These studies were based on 
the size difference between the insertion and absence (null allele) of the Alu element by 
amplifying the whole region with the same primers [61]. However, with this inherent size 
difference greater than 300 bp between the two allelic states (insertion and null alleles, 
INNULs) was quite difficult to use retrotransposons for human identification [54]. This 
limitation is due to the wide difference between amplicons of INNULs caused in 
amplification efficiency during PCR, once there is a preferential amplification of the 
smaller allele and possibly the drop-out of the insertion element [55, 61].  
To overcome the limitations that prevented the use of Alu elements for human 
identification, a new primer design methodology (Mini-Primer Strategy) has been 
developed. This methodology removes the intra-specific locus competitiveness in 
heterozygous by reducing the overall amplification size as well as the difference in 
amplification sizes amongst the two allelic states of INNULs. Thus, the resulting INNUL 
allelic amplicons can differ by as little as one base pair instead of the previous nearly 300 
bp and can be reduced to smaller sizes than those presented by the STRs markers [54, 
55, 61]. 
InnoTyper® 21 kit is a multiplex system based on Alu elements to determine small 
amplicon fragments (60 - 125 bp). It is compatible with existing PCR and capillary 
electrophoresis platforms and may be an optimum system to be used for DNA typing of 
highly degraded and/or low quality samples [62]. This multiplex system consists of 21 
genetic markers, including 20 retrotransposons and Amelogenin [54]. For each marker, 
amplification of the two allelic states of INNUls is preformed using a common unlabeled 
forward primer and two fluorescently labeled reverse primers (Figure 1.13). The forward 
primer (CF) is used either for inserting or the absence of the retrotransposon. The labeled 
reverse primer for the null allele (RN) overlaps the insertion site of the RE and anneals 
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in its absence. The labeled reverse primer for the insertion allele (RI) has an overlap 
region with the junction and the retrotransposon itself, or just inside the retrotransposon, 
and when retrotransposon is present, the annealing site of the reverse primer is disrupted 
allowing the anneal of the insertion specific reverse primer at the site that overlaps with 
the insertion site and the adjacent portion of retrotransposon [55, 61]. 
 
Figure 1.13 -Amplification strategy of InnoTyper® 21 kit (Adapted from LaRue et al., 2012 [55]) 
The selection of genetic markers to include in multiplexes must be careful and include 
markers that are highly polymorphic in all major populations (i.e., reaching 50% 
heterozygosity) and therefore desirable for testing human identification, as well as 
markers with high inbreeding coefficients (such as SNPs) which allow bio-ancestry 
analysis. Thus, the markers used for the development of InnoTyper® 21 kit are based on 
Alu elements and were selected based on molecular characteristics and existing 
population data [61] (Appendix I).  
This amplification system is useful for the DNA analysis of forensic samples, presenting 
high discrimination power for samples previously analyzed with conventional STR 
methods that rendered no results, such as rootless hair shafts and degraded DNA 
samples. Their bi-allelic nature offers the advantage of type only two alleles for genetic 
marker, and thus simplifying the analysis and interpretation of results. However, 
InnoTyper® 21 kit presents limitations in the interpretation of samples containing DNA 
mixture when used in conventional capillary electrophoresis (CE) platforms. The same 
is not expected to happen whenever the analyses of DNA mixtures are performed in 
NGS platforms [54]. It is important to mention that it is possible to perform population 
statistical analysis with InnoTyper® 21 kit. However, the existing allelic frequencies were 
calculated from the American population database samples. Therefore, the lack of a 
Portuguese population database for retrotransposons-based genetic markers represents 
another limitation for the use of this kit. 
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1.4. Internal validation for forensics laboratories 
The implementation of new procedures, methods, kits, software or equipment in forensic 
laboratories to obtain results leading to the conviction or acquittal of a suspect should be 
carefully evaluated and validated. When discussing the importance of maintaining good 
laboratory practice to obtain accurate scientific results have to take into consideration 
the quality assurance and quality control. Quality assurance refers to planned or 
systematic actions that are necessary to provide adequate confidence that a product or 
service will satisfy certain quality requirements. Quality control refers to daily operating 
techniques and the activities used to meet the quality requirements. As such, an 
organization plans quality assurance measures and performs quality control activities in 
the laboratory [6]. 
The constant development of new methodologies for DNA testing leads to a constant 
process of validation in forensic laboratories [59]. Validate a particular laboratory process 
is to demonstrate that it is robust (successful results are achieved a high percentage of 
the time and few, if any, samples need to be repeated), reproducible (equal or very 
similar results are obtained every time a sample is tested) and reliable (the results 
obtained are accurate and correctly reflect the sample being tested) through a defined 
range of conditions [6, 63]. Two types of validation exist: i) developmental validation is 
performed by the manufacturer of a DNA test or a group of laboratories with the intuit to 
test new kits, new primers sets and new technologies for detecting alleles; ii) internal 
validation, more specific to the needs of a particular forensic laboratory, consists of 
verifying that the established procedures examined previously by developmental 
validation given by another laboratory will work effectively in the laboratory [6, 63]. 
Validation guidelines in DNA analysis have been previously published by Technical 
Working Group on DNA Analysis Methods (TWGDAM) in 1989, 1991 and 1995, but in 
July 2004, the FBI’s Scientific Working Group on DNA Analysis Methods (SWGDAM) 
published revised validation guidelines providing more detailed validation information 
[63, 64]. In December 2012, SWGDAM made minor revisions to the 2004 validation 
guidelines, and the internal validation process was changed to included five studies 
(known and nonprobative evidence samples, sensitivity and stochastic studies, precision 
and accuracy, mixture studies, and contamination assessment) [65].  
Known and nonprobative evidence samples refers to methods proposed for casework 
samples that must be evaluated and tested using known samples, nonprobative 
evidence samples or mock case samples and, when possible, authentic case samples. 
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Results from these studies must be compared to the previous results of known samples 
and/or nonprobative evidence or mock case samples to guarantee concordance [65].  
Sensitivity and stochastic studies are used to demonstrate sensitivity levels of the test. 
As such, by testing a range of DNA concentrations, these studies estimate the dynamic 
range, ideal target range, limit of detection, limit of quantitation, heterozygote balance 
(e.g., peak height ratio), and the signal to noise ratio associated with the assay. 
Sensitivity studies may also be used to assess stochastic effects (stochastic threshold) 
usually resulting from low quantity and/or low quality samples [65, 66]. 
Precision and accuracy are demonstrated by repeatability and reproducibility tests. 
Reproducibility tests are used to evaluate the variation in average obtained by different 
operators using the same measurement equipment to measure repeatedly the same 
sample. Repeatability tests are used to evaluate the variation of the measures obtained 
by a single operator, using the same measurement equipment and method, to measure 
repeatedly the same sample [65, 67]. 
Mixture studies are conducted to help forensic laboratories to establish guidelines for the 
interpretation of mixed DNA samples which are those usually found at crime scenes. 
These guidelines include determination of the number of contributors to a biological 
mixture, determination of the major and minor contributor profiles, and contributor ratios 
or proportions. Results from mixture tests can also be used to evaluate laboratories 
contamination [65, 66]. 
Finally, contamination assessment is performed using negative controls as well as 
known samples, to detect exogenous DNA (including allele drop-in and heteroplasmy) 
which may be originated from reagents, consumables, operator and/or laboratory 
environment [65, 66]. 
According to the European Network of Forensic Sciences Institutes (ENFSI) for a certain 
forensic laboratory implement new DNA quantification system and/or new multiplex kit 
(as is the case of the present work), at these minimum parameters to be validated 
internally must be added concordance studies. 
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2. Material and Methods 
The practical component of this work was developed at the Forensic Specialty of Biology, 
in the Biotoxicology area of the Laboratório de Polícia Científica da Polícia Judiciária 
(LPC-PJ). The LPC is a unit of the PJ that supports criminal investigation, with scientific 
and technical autonomy to develop its activities with independence, impartiality and 
integrity. This activity is applied to multiple fields of forensic science and, in scientific 
technical terms, is organized into three main areas: Biotoxicology, Criminology and 
Physical Document.  
The Forensic Specialty of Biology is inserted in the Biotoxicology area and performs 
forensic tests within the biology and genetics criminalistics, such as search and 
characterizing of biological traces; determining genetic profiles (autosomal STRs and Y 
chromosome markers); comparing genetic profiles; evaluating results by statistical 
analysis; bioresearch kinship in criminal situations; and sending genetic profiles to the 
“Base de Dados de Perfis de ADN”, as determined by Law 5/2008 of 12 February. 
This laboratory analysis of forensic samples requires the use of a set of preventive 
measures to avoid any undesirable contamination that may adversely alter the results. 
Thus, the LPC has implemented various procedures to prevent contamination, 
exchanges or any other error that may arise in the treatment of cases, lying currently in 
the process of obtaining accreditation of NP EN ISO/IEC 17025, having submitted the 
case to the Instituto Português de Acreditação (IPAC). 
In the Forensic Specialty of Biology from LPC-PJ are analyzed two types of forensic 
samples: reference samples corresponding to samples that are properly identified and 
which have a reasonable DNA quantity and quality, and casework samples of unknown 
origin and compromised DNA quantity and quality. All the samples received in the LPC 
for analysis are properly identified with the examination number and a preparation 
number assigned by the preparation models developed by the service.  
One of the first methods to prevent cross-contamination in LPC-PJ is the assignment of 
two independent and separate rooms for processing both types of samples, to certify the 
veracity of the results. The LPC-PJ also has a pre-PCR room for the plates preparation 
of quantification and amplification of each of these types of sample, as well as a post-
PCR room. To circulate within these rooms is required the use of exclusive work clothes 
(gown, disposable gloves and masks), taking care to not circulate between different 
rooms with work clothes that are using in a particular room. The same applies for 
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transportation of materials and/or equipment. Before and after any laboratory procedure 
that refer to the use of a room, workbench, workstation and/or utensils, the same must 
be sterilized using ultraviolet light (UV) and/or washing with sodium hypochlorite and 
subsequent passage by ethyl alcohol. Another parameter for prevention of contamination 
is the addition of a negative control in all the different stages of analysis in order to enable 
monitoring of these contaminations. 
2.1. Sample selection 
Challenging samples such as hairs, blood, contact trace, bones fragments and teeth 
were chosen from extracts of LPC-PJ casework, based on its profiles (no results, 
inconclusive results, and possible degradation) and quantification values. Samples that 
matched the guidelines of the ENFSI guidelines [67] were also selected as control. 
Additionally to the casework samples whose extraction is performed from hairs with 
follicle was, a new set of samples of rootless hair was also included.  
2.2. Extraction Methods 
DNA extractions from samples selected from existing LPC extracts were performed using 
the commercial kit PrepFiler™ BTA Forensic DNA Extraction in the equipment 
AutoMate™ Express Instrument, both used according to the protocol, within a laminar 
flow camera to prevent contamination (Appendix II, Figure 1). Thus, each sample was 
cut to a PrepFiler column to which was added 260 μL of a mixture containing 248 μL of 
PrepFiler™ BTA Lysis Buffer; 3.4 μL of 1M Dithiothreitol (DTT) solution and 7.9 μL of 
proteinase K. The set "PrepFiler" column/tube was placed into the TERMOMIXER at 56 
ºC for 40 minutes at 900 rpm. The set column/tube was centrifuged for two minutes at 
10000 rpm. Finally, after checking whether the end of the tube was a volume of at least 
150 μL, the column was discarded and the tube preserved for AutoMate™ Express 
Instrument use. For the set of 40 samples whose extraction was performed from rootless 
hair samples, the extraction method used was the same as that used by InnoGenomics 
Technologies [62]. For this, the hair selected for this set of samples was observed under 
a microscope to identify the presence of the root, which was subsequently removed with 
a sterile scissors. A hair fragment with approximately 2 cm was cut and placed inside a 
tube to be cleaned by sonication in 5 % Terg-a-zyme, for 20 minutes, followed by a rinse 
in 100% ethanol and molecular biology grade water. DNA extraction was performed 
using the commercial kit PrepFiler™ BTA Forensic DNA Extraction (according to protocol 
with minor modifications) in the equipment AutoMate™ Express Instrument. Each hair 
fragment was placed inside a PrepFiler column and added 260 μL of a mixture containing 
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248 μL of PrepFiler™ BTA Lysis Buffer; 3.4 μL of 1M Dithiothreitol (DTT) solution and 
7.9 μL of proteinase K. The set column/tube was placed in the TERMOMIXER at 56 ºC 
for 60 minutes at 900 rpm. Then 200 μL of Buffer AL were added and samples were 
incubated for 10 minutes. After, all procedures were performed as described by user 
protocol and in accordance with what has been above reported for samples of the LPC 
extracts. 
2.3. Quantification Method - InnoQuant® HY kit 
The DNA quantification of selected samples was performed with the InnoQuant® HY kit 
(Table 2.1) according to the manufacturer's instructions, described in the InnoQuant® HY 
Human and Male DNA Quantification & Degradation Assessment Kit user guide v1.2. 
Table 2.1 - InnoQuant® HY Kit contents. 
InnoQuant® HY 
Kit Reagents 
InnoQuant® HY Primer Mix 
InnoQuant® HY DNA Standard at 100 ng/μL 
InnoQuant® HY Dilution Buffer A 
Agilent Technologies Brilliant Multiplex QPCR Master Mix 
ROX reference dye at 1mM 
Before starting any quantification/amplification/capillary electrophoresis run, a planning 
sheet (or plate layout) was created to serve as guidance during the plate preparation. 
For this purpose, the Forensic Specialty of Biology from LPC has created files templates 
(models) originated from the results analysis, not only allowing automate procedures, but 
also serving as quality control. All the procedures to prepare the plate for the 
quantification of DNA were performed in a pre-PCR room of sample problem, inside of a 
laminar flow chamber previously irradiated with ultraviolet radiation (UV) to prevent any 
contamination. Since InnoQuant® HY kit (Appendix III, Figure 1) was designed to be 
highly sensitive, it is extremely important have in attention their storage conditions (as 
fluorescent dyes attached to the probes are light-sensitive, the InnoQuant® HY Primer 
Mix and the Agilent reference dye should be protect from light when not in use) and 
aseptic working conditions. 
2.3.1. Preparation of DNA Standards 
To initiate a quantification reaction must be previously prepared serial dilutions of 
InnoQuant® DNA HY Standard, whose obtained values will be used to draw a calibration 
curve. These serial dilutions were made in duplicate to enable the increased precision of 
the calibration curve. According to the manufacturer's recommendations, five dilutions 
standards with known concentrations were prepared from the original solution of 100 
ng/μL varying their concentrations from 20 ng/μL until 0.005 ng/μL. These five solutions 
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were prepared with the InnoQuant® HY Dilution Buffer A, such as is described in the 
Table 2.2. 
Table 2.2 - Preparing serial dilutions from the initial solution of 100 ng/μL. 
Standard 
Concentration 
(ng/μl) 
Recommended dilutions amounts 
Dilution 
factor 
Std. 1 20 
10 μL [Stock 100 ng/μL] + 40μL Dilution Buffer 
A 
5X 
Std. 2 2.5 10 μL [Std. 1] + 70 μL Dilution Buffer A 8X 
Std. 3 0.3125 10 μL [Std. 2] + 70 μL Dilution Buffer A 8X 
Std. 4 0.0391 10 μL [Std. 3] + 70 μL Dilution Buffer A 8X 
Std. 5 0.005 10 μL [Std. 4] + 70 μL Dilution Buffer A 8X 
To prepare the dilutions was necessary equilibrate InnoQuant® DNA HY Standard to 
room temperature, for 15 minutes and when defrosted, vortexed for five seconds and 
centrifuged for 10-15 seconds at 3000 rpm (protected from light). After, fresh serial 
dilutions were performed by the mixture of InnoQuant® DNA HY Standard with 
InnoQuant® HY Dilution Buffer A in low adhesion tubes.  
2.3.2. Reaction and Sample Setup 
The preparation of the diluted standards for the calibration curve was followed by the 
preparation of reaction mix composed by InnoQuant® HY Primer Mix, Agilent 
Technologies Brilliant Multiplex QPCR Master Mix, and Agilent reference dye reagents, 
as shown in Table 2.3. 
Table 2.3 - Components required for master mix preparation and required volume for each reaction. 
PCR Components Volume per reaction 
Agilent Technologies Brilliant Multiplex QPCR Master Mix 10 μL 
Agilent reference dye (2 μM) 0.3 μL 
InnoQuant® HY Primer Mix 7.7 μL 
Total Volume 18 μL 
These reagents must be equilibrated at room temperature for 15 minutes in the dark 
before use. Then, 1 μL of 1mM Agilent reference dye was added to 499 μL nuclease-
free water for a final concentration of 30 nM in the PCR reaction. Then, the reaction mix 
was prepared by combining the master mix, primer mix and reference dye, with the 
calculated volume per reaction as indicated in table 2.3 and vortexed. In a 96-well 
reaction plate were dispensed 18 μL of the reaction mix into each appropriate well and 
2 μL of DNA standard dilutions, followed by the unknown samples and 2 μL of 
InnoQuant® HY Dilution Buffer A as negative control (or NTC from “no template control”). 
The plate was sealed with an optical adhesive cover using the plate cover applicator, 
and centrifuged for one minute at 1500 rpm.  
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After, the plate is then introduced in the 7500 HID Real-Time PCR equipment existing in 
the LPC-PJ to run (Appendix II, Figure 2). 
2.3.3. 7500 Instrument Setup 
Before running, the equipment was calibrated for FAM, Cy5, TAMRA, and HEX dyes. 
The calibration plates for these dyes were provided by InnoGenomics Technologies in 
the InnoQuant® Spectral calibration kit (Appendix III, Figure 2). 
Quantification run comprises an initial heating time followed by 40 cycles of PCR as 
shown in figure 2.1. 
 
Figure 2.1 - Cycling parameters of Quantification run. 
The analysis software generated calibration curves based on standards and calculated 
the DNA concentration in each sample. The reaction efficiency values must be greater 
than 90 % for the Short, Long, and Y targets; acceptable slope values must be between 
-3.6 and -3.1; and R2 values must be greater than 0.98. Regarding to IPC target it is 
expected to have CT values no more than 2 units above the mean IPC CT for all 
quantification standards on the plate. 
2.4. Amplification Method - InnoTyper® 21 kit 
The DNA amplification of selected samples was performed with the InnoTyper® 21 kit 
(Table 2.4) according to the manufacturer's recommendations which are described in the 
InnoTyper® 21 Human DNA Analysis Kit user guide v3.7. 
Table 2.4 – InnoTyper® 21 Kit contents. 
InnoTyper® 21 
Kit Reagents 
InnoTyper® 21 Primer Mix 
InnoTyper® 21 Master Mix  
IGT DNA Polymerase 
DNA Control at 0.12 ng/μL 
InnoTyper® 21 Allelic Ladder 
ILS-155 Internal Lane Standard 
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All procedures were performed in the pre-PCR room of sample problem, inside a laminar 
flow chamber previously irradiated with ultraviolet radiation. InnoTyper® 21 kit (Appendix 
III, Figure 3) was designed to be highly sensitive and contains fluorescent dyes, being 
important to have precautions concerning storage conditions and light exposure. 
2.4.1. PCR reaction Setup 
The PCR reaction mix and the volume calculation of each component were prepared 
according to Table 2.5. 
Table 2.5 - Components required for master mix preparation and required volume for each reaction. 
PCR Components for Multiplex 
Volume per reaction 
25 μL Total reaction Mix 
InnoTyper® 21 Primer Mix 3.5 μL 
InnoTyper® 21 Master Mix 5.0 μL 
IGT DNA Polymerase 0.5 μL 
DNA template/ Positive Control/ TE-4 buffer Up to 16.0 μL 
The InnoTyper® 21 Primer Mix, InnoTyper® 21 Master Mix, and IGT DNA polymerase 
were thaw and equilibrated to room temperature. After, these reagents were vortexed for 
3-5 seconds and centrifuged for two seconds. To prepare the reaction mix, the required 
volumes of master mix, primer mix, and DNA polymerase multiplex components was 
pipetted into a sterile 1.5 mL polypropylene tube which was vortexed for 5-10 seconds 
and centrifuged for two seconds. In a 96-well reaction plate, 9 μL of the reaction mix 
were dispensed. Samples were prepared according to the Table 2.6 and added to the 
reaction mix for a final reaction volume of 25 μl. For selected samples, the results 
obtained by quantification allowed to determine the DNA extract volume to be added to 
the amplification reaction, to obtain a maximum input of 0.5 ng/μL. The final reaction mix 
and samples were mixed and the plate was sealed with an optical adhesive film using 
the plate cover applicator. 
Table 2.6 - Components and volume required in preparing samples for the PCR reaction. 
Sample Components and Volume 
Negative Control Add 16.0 μL of TE-4 buffer (10 mM Tris; 0,1 mM EDTA, pH 8.0) 
Positive Control 
Add 4.0 μL of provided DNA Control plus 12.0 μL of TE-4 buffer 
(DNA Positive Control should be equilibrated at room 
temperature, vortexed, and centrifuged briefly prior to adding 
into the reaction) 
Test Sample 
Add up to 16.0 μL of the DNA sample to the reaction mix (if the 
required sample volume was less than 16.0 μL, it was added the 
required volume of TE to totalize the 16.0 μL needed) 
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2.4.2. PCR Amplification 
Once the plate prepared, was loaded to the thermal cycler GeneAmp® PCR System 9700 
with gold-plated silver 96-Well Block equipment existing in post-PCR room of LPC-PJ, 
using the 9600 Emulation Mode and the heated cover was closed (Appendix II, Figure 
3). An adhesive clear film was used to seal the plate wells and a MicroAmp® compression 
pad was positioned on top of the plate to prevent evaporation during thermal cycling. 
The thermocycler programming conditions for the PCR amplification reaction are 
described in Figure 2.2. 
 
Figure 2.2 - Amplification program from InnoTyper® 21 kit. 
At the end of amplification, samples were inserted in the automatic sequencer 3130XL 
Genetic Analyzer (Applied Biosystems), where the amplified products are separated and 
detected by a capillary electrophoresis process (Appendix II, Figure 4).  
2.4.3. Genetic Analysis 
To perform the genetic analysis, it is necessary that the InnoGenomics IGT 5 Dye Matrix 
Standard matrix file exists in the 3130XL Genetic Analyzer. The IGT 5 Dye Matrix 
Standard (Appendix III, Figure 4) consists of DNA fragments labeled with five different 
fluorescent dyes (FAM, JOE, TMR, ROX, and TGI-ORANGE) used to perform a spectral 
calibration on a specific dye set (in this case, G5). Once generated, this file was applied 
during sample detection to calculate the spectral overlap between the five different dyes 
and separate the raw fluorescent signals into individual dye signals. The matrix standard 
was prepared by combining the components as described in Table 2.7. To this, it was 
necessary first to thaw and mixe the matrix standard by vortexing for 10 seconds. Then, 
10 μL of this mixture was dispensed in 16 reaction well of the plate, sealed with septa 
strip, and placed in the thermal cycler at 95 ºC for three minutes to denature the DNA. 
Finally, the plate was covered with plate retainer, placed into autosampler tray, and run. 
Table 2.7 – Components and volumes required for the Matrix Standard preparation. 
Components Volume to 3130XL 
IGT 5 Dye Matrix Standard 18 μL 
HI-DITM Formamide 162 μL 
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The spectral calibration was performed as described in the ABI 3130XL Genetic Analyzer 
user manual with only few modifications described in the Multi-Capillary IGT 5 Dye Matrix 
Standard ABI 3130 & 3500 Series Genetic Analyzers.  
2.4.3.1. Sample preparation and data analysis using GeneMapper® ID-X 
Samples were prepared based on the components and volumes shown in the Table 2.8.  
Table 2.8 - Components and volumes required for the Sample preparation. 
Components Volume to 3130XL 
Hi-DiTM Formamide 10.8 μL 
ILS-155 Internal Lane Standard 0.2 μL 
After prepared, the formamide/size standard mixtures were vortexed and centrifuged. 
On the 96-well sample plate were dispensed 11 μL of the mixture and 1 μL of PCR 
product or allelic ladder (Appendix III, Figure 5) which was them mixed (is critical to use 
an allelic ladder run under the same conditions as the samples because size values 
obtained for the same sample can differ between instrument platforms due to different 
polymer matrices and electrophoretic conditions). The reaction plate was sealed with 
appropriated septa, and placed in a thermal cycler for three minutes at 95 ºC.  
The results produced by the capillary electrophoresis instrument were provided as 
electropherograms, posteriorly analyzed using the GenneMapper® ID-X v1.4 software. 
2.5. The use of Qiagen® QIAgility™ robot 
In this study, the Qiagen® QIAgility™ robot was also used to evaluate the possibility of 
automatization of these kits. The QIAgility™ robot was designed to perform rapid, high-
precision automated PCR setup and liquid handling actions in molecular biology 
applications. The use of this automated instrument enables to decrease the number of 
human faults that can occur during repetitive steps during the DNA analysis process. 
The QIAgility™ robot was used to prepare the DNA Standards required for DNA 
quantification as well as pipetting 18 μL of the master mix into each well of the 96-well 
quantitation plate and 2 μL from each sample or DNA standard. This instrument was also 
used in the PCR plate preparation pipetting 9 μL of the reaction mix into each well of the 
96-well followed by the required volume of each sample (test sample, negative control 
and positive control) necessary to a final reaction volume of 25 μL (Appendix II, Figure 
5). It was also used in the post-PCR room for preparing the plate for capillary 
electrophoresis, to mixture 11 μL of formamide/size standard and 1 μL of PCR product 
or allelic ladder (Appendix II, Figure 6). All procedures performed by this automated 
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instrument were according to the requirements of the kits manufacturers described in the 
user guides. The use of two different techniques (manual and automated) for the 
preparation of quantification and amplification plates also will serve as an internal 
validation method. 
2.6. Internal validation procedures 
The parameters analyzed for the internal validation of InnoQuant® HY and InnoTyper® 
21 kits were the minimum required by the ENFSI and include sensitivity, repeatability 
tests, reproducibility tests, and mixture studies. Additionally, to these parameters, a 
concordance study between the results obtained with the STR kits currently used by 
LPC-PJ (Quantifiler® Duo and GlobalFiler™) and the results obtained in the 
quantification and amplification kits were compared.  
For the InnoQuant® HY kit, the evaluation of these parameters were considered the 
results for the Short target, since this target represent the total DNA present in the 
sample. In the mixture studies, were also considered the results obtained for the Y 
chromosome target, concerning the quantification of male DNA. For InnoTyper® 21 kit, 
the evaluation of these parameters was performed based on the percentage of amplified 
fragments and it subsequently detection by capillary electrophoresis (profile quality), with 
different injection times. 
2.6.1. Sensitivity 
The sensitivity test for the InnoQuant® HY kit was performed using a series of six dilutions 
(from 1 – 0.03125 ng/µL) from InnoQuant® HY DNA standard, tested in duplicate. As 
InnoQuant® HY DNA standard has an initial concentration of 100 ng/µL was proceeded 
to an initial 1:10 dilution yielding a new dilution with concentration of 10 ng/µL and then 
it proceeded further dilution 1:10 creating a dilution with 1 ng/µL from which was carried 
out the serial dilution required to this study. For the InnoTyper® 21 kit, this test was 
performed by the amplification of a series of five positive controls with different input 
volumes (5 µL, 4 µL, 3 µL, 2 µL, 1 µL) with concentrations ranging from 6.0 ng/µL to 0.12 
ng/µL, prepared from InnoTyper® 21 DNA Control and tested in duplicates.  
2.6.2. Precision and accuracy 
In the study of the precision and accuracy of these kits, repeatability and reproducibility 
tests were performed. Thus, for the InnoQuant® HY kit these tests were based on the 
analysis of the CT values obtained for the five standards used to create the calibration 
curve. These five standards were performed in duplicate and analyzed in four different 
FCUP 
Evaluation and validation of retrotransposons-based kits for DNA analysis of degraded biological evidence and rootless 
hair 
- 30 - 
 
 
quantification runs, thus obtaining eight CT values for each standard in all the four 
quantification runs. For the InnoTyper® 21 kit, the performance of these tests was based 
on the amplification of the same series of five positive controls used in sensitivity tests, 
with different injection times tested in duplicates. During the validation of the kits two 
different methodologies (manual and automatic) were used and the results obtained by 
both enable the verification of the reproducibility of the kits. 
2.6.3. Mixture studies 
This parameter was only evaluated for the validation of InnoQuant® HY kit since the 
InnoTyper® 21 kit presents limitations in the interpretation of samples containing DNA 
mixture when used in conventional capillary electrophoresis. The validity of this study 
was performed by preparing mixtures from a male sample and a female sample, with 
known concentrations. For this, both samples were normalized to a concentration of 0.5 
ng/µL and the preparation of mixture set was performed as described in Table 2.9 in 
order to test the ability of InnoQuant® HY kit to determine the two contributors in these 
proportions. 
Table 2.9 – Volume of each diluted DNA sample required to prepare the mixture set. 
Mixture Ratio 
 19:1 9:1 3:1 1:1 1:3 1:9 1:19 
Female Sample 95µL 90 µL 75 µL 50 µL 25 µL 10 µL 5 µL 
Male Sample 5 µL 10 µL 25 µL 50 µL 75 µL 90 µL 95 µL 
2.6.4. Concordance study 
The concordance study was conducted by comparing the results obtained with these 
new quantification and amplification kits using retrotransposons as genetic markers with 
the kits currently in use in the LPC, Quantifiler® Duo and GlobalFiler™, which use 
conventional STRs as genetic markers. Thus, from the samples selected from existing 
extracts of the LPC-PJ casework previously quantified with Quantifiler® Duo kit and 
amplified with GlobalFiler™ kit, and whose quantification results were not concordant 
with the genetic profiles produced, 132 samples were tested with InnoQuant® HY kit and 
the results obtained were compared with those previously obtained by Quantifiler® Duo. 
The same procedure was performed to the concordance study of amplification kit, in 
which the 132 samples quantified with InnoQuant® HY kit were amplified with InnoTyper® 
21 kit and the genetic profiles produced were compared to previously obtained with the 
GlobalFiler™ kit. 
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2.7. Evaluation of InnoQuant® HY and InnoTyper® 21 kits in 
rootless hair analysis 
To evaluate the performance of both kits in rootless hair samples, 40 samples were 
analyzed in which the existing roots were removed by cutting. The DNA extraction 
methodology was similar to the one currently used by LPC-PJ, with some modifications, 
mainly the samples incubation time (which is higher) and the addition of buffer AL. These 
samples, obtained from crime scenes, were quantified with InnoQuant® HY kit and 
amplified with InnoTyper® 21kit. Thus, this evaluation besides allowing to know the 
behavior of both kits for this type of samples, allowing to determine the level of 
degradation to the samples sent to the LPC-PJ (through the degradation index calculated 
by the InnoQuant® HY kit) and obtaining amplified fragments from rootless hair samples. 
2.8. Statistical analysis 
Data were statistically analyzed using Microsoft Excel 2010. T-student and Chi-square 
tests were performed to establish the significance of the results obtained. P values of 
0.05 or lower were considered statistically significant. Results were expressed as the 
mean ± S.E.M. of the indicated number of experiments. 
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3. Results and Discussion 
3.1. Sample selection 
Sample selection, made from existing extracts of LPC-PJ, was accomplished through 
extensive analysis of all the exams admitted in the forensic specialty of Biology, since 
2015. From each exam analyzed, several samples of blood, contact trace, teeth and 
hairs were chosen. This choice was based on the results of the genetic profile (no results, 
inconclusive, complete, and/or possible degradation/inhibition) produced by the 
amplification kit currently at use in the LPC-PJ as well as in the quantification results 
presented. After, samples were divided into six separate groups according to the genetic 
profile presented, as represented in Table 3.1 (Appendix IV). 
Table 3.1 – Type of selected samples and their division according to the genetic profile presented. 
Group Sample Ext Trace Quantification value (QD) Type of profile 
I 
1 430-11 Hair ------------ 
No Results 2 442-02 Hair ------------ 
3 442-07 Hair ------------ 
II 
40 442-01 Hair ------------ 
Inconclusive 42 358-03 Hair 0.003 
43 442-04 Hair ------------ 
III 
56 430-04 Hair 0.001 
Complete 57 447-08 Hair 0.024 
58 442-09 Hair 0.087 
IV
 
IP
C
 +
 
64 452-12 Biologic ------------ No Results 
65 454-06 Biologic ------------ No Results 
66 454-06 Biologic ------------ No Results 
V
 
D
e
g
ra
d
e
d
 
D
N
A
 
84 465-02 RS 0.006 
Inconclusive 
85 457-17 RS 0.006 
86 457-03 RS 0.010 
87 447-05 Hair 0.011 
88 375-24 RS 0.012 
V
I 
D
e
g
ra
d
e
d
 o
r 
in
h
ib
it
e
d
 D
N
A
 
113 101-01 Teeth ------------ No Results 
114 113-02 Teeth ------------ No Results 
115 113-01 Teeth 0.001 No Results 
116 113-03 Teeth 0.260 Complete 
118 126-04 Teeth 0.008 Inconclusive 
119 122-03 Teeth ------------ No Results 
Additionally, another set of 40 rootless hair samples extracted using manufacturer’s 
instructions (InnoGenomics Technologies) was included to determine the behavior of the 
InnoQuant® HY and InnoTyper® 21 kits in this type of samples, often sent to the LPC-PJ 
and that mostly do not produce results. 
To internally validate the InnoQuant® HY and InnoTyper® 21 kits, the InnoQuant® HY 
DNA Standard and the InnoTyper® 21 DNA Control, respectively, were used as samples. 
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3.2. Internal Validation of InnoQuant® HY kit 
The DNA quantification of a given sample is an extremely important step in forensic 
laboratories, since it allows to determine not only the approximated concentration of DNA 
present in a given sample but also its quality, and thus select the most suitable 
amplification method to be used. Thus, knowing the best amplification kit to be used and 
the optimal volume of DNA required for the run, allows saving time and financial 
resources. 
One the mainly aims of the present study was the internal validation of InnoQuant® HY 
kit, a human and male quantification and degradation assessment kit, for later 
implementation in the LPC-PJ laboratory routine. To this, sensitivity, repeatability, and 
reproducibility parameters, as well as mixtures studies were evaluated. 
3.2.1. Sensitivity 
To study the sensitivity of the quantification kit was prepared a serial dilution of the 
InnoQuant® HY DNA Standard (1.0 ng/µL; 0.5 ng/µL; 0.250 ng/µL; 0.125 ng/µL; 0.063 
ng/µL and 0.031 ng/µL) and tested in duplicate. An intermediate dilution of 10 ng/µL 
(performed due to the fact that the standard DNA having an initial concentration of 100 
ng/µL) it was also analyzed. All dilutions were quantified according to manufacturer’s 
instructions, and using two different methodologies - manual and automated (QIAgility™ 
robot). The results for the short target are described in the Table 3.2. The quantification 
results for all the targets analyzed by InnoQuant® HY, for both methodologies can be 
observed in Appendix V. 
The aim of this study was to evaluate the kit ability to measure very low DNA 
concentrations, as well as comparing expected results with the respective quantification 
values obtained. 
Table 3.2 – Quantification results obtained for the intermediate and serial dilution with the InnoQuant® HY kit using manual 
and QIAgility™ robot procedures. 
Dilution 
Expected values 
(ng/µL) 
Observed values (ng/µL) - 
QIAgility™ robot 
Observed values 
(ng/µL) - Manual 
1st repetition 2nd repetition 1st repetition 
Intermediate 10 13.067 11.288 Not analyzed 
Dil.1 1.0 1.097 1.133 0.900 
Dil.2 0.500 0.676 0.601 0.463 
Dil.3 0.250 0.284 0.299 0.215 
Dil.4 0.125 0.143 0.141 0.124 
Dil.5 0.063 0.064 0.071 0.056 
Dil.6 0.031 0.034 0.038 0.033 
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Using both methods, the concentrations obtained for the serial dilutions were very similar 
to the expected theoretical concentrations. In intermediate dilution, the observed values 
were slightly different, although not significant [p > 0.05 (Appendix V)], from the expected 
theoretical values, a fact that may be attributed to pipetting errors made by the QIAgility™ 
robot or to the dilution factor, since the variability encountered with pipetting larger 
dilutions resulted in larger deviations from the expected values. Also, the quantification 
method did not provide the exact amount of DNA present in a given sample, but 
approximate results. Thus, it was verified that this quantification kit was able to quantify 
samples containing both large and reduced DNA concentrations, presenting, therefore, 
good sensitivity. 
3.2.2. Repeatability and Reproducibility 
To study repeatability and reproducibility was performed the analysis of CT values 
obtained for the five standards used to create the calibration curve (four independent 
quantification runs). Three of these quantification plates were performed by QIAgility™ 
robot, at different times, and the fourth run was manually prepared and applied in the 
following day. Thus, as the same standards were prepared and applied at different times 
and on different days, being possible to verify the repeatability of the kit. The preparation 
and application of standards using two different operators (manual and automated) 
allowed evaluating its reproducibility. All quantification plates were run on ABI 7500 HID 
Real-Time PCR System. 
For each of the three quantification runs performed for the evaluation of these 
parameters, the QIAgility™ robot prepared dilutions from InnoQuant® DNA HY Standard 
solution, as described in the kit user manual. Thus, five standards were obtained, with 
concentrations of 20 ng/µL; 2.5 ng/µL; 0.3125 ng/µL; 0.0391 ng/µL and 0.005 ng/µL. 
Each standard was applied in duplicate in each run, producing six CT values (CT 1 to CT 
6) in the set of three automated runs. To perform the fourth run, the same dilutions were 
manually prepared and applied, in duplicate, producing more two CT values: CT7 and 
CT8. 
The CT values for each standard of the short target in the four quantification runs 
prepared are illustrated in Figure 3.1 (Appendix VI).  
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Figure 3.1– CT values obtained for the short target of five Standards in the three quantification runs. 
Considering the same run, no significant statistically differences of CT values between 
duplicates were observed, as well as among the different standards (p > 0.05). The same 
was observed for the fourth run, except for the standards 1 and 5 (20 ng/μL and 0.005 
ng/μL, respectively) whose values between duplicates were different, although without 
compromising the results (Appendix VI). This difference may be related to the fact that 
these standards presented higher and lower concentrations, respectively. 
Also, as the concentration of DNA standards decreases, an increase of the CT values 
was detected. This was observed in all quantification runs and presented the inverse 
proportionality between the concentration values of the DNA standards and the CT 
values. These data demonstrated the high consistency of the kit. 
Comparing the CT values obtained for the three quantification runs prepared by the robot 
(CT1 to CT6) with the CT values in the manual run (CT7 and CT8), an increase in the CT 
values for this last run was observed. This variability may be associated with a variation 
in the machine conditions since the runs were performed on different days by different 
operators, as well as the fact that the preparation of the standards for the manual run 
was performed from a new InnoQuant® DNA HY Standard solution. However, it is 
important to note that these changes observed for the CT values between runs were not 
significant (p > 0.05) (Appendix VI) and, therefore, did not affect the kit reproducibility, 
since all values were within the optimal range of 30 CT stipulated by manufacturers. 
For each of the three quantification runs prepared by the robot, the respective calibration 
curve for DNA concentration was drawn, using the CT average values from each 
standard. It was also drawn a calibration curve for the set of the runs (Av. run), 
considering the average values of total CT obtained for each of the five standards. These 
calibrations curves are illustrated in Figure 3.2. The calibration curve in function of the 
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DNA concentration logarithm was also designed to the fourth quantification run and is 
illustrated in Figure 3.3. 
 
Figure 3.2 - Calibration curves designed for each quantification run performed by the robot as well as for the average run 
(Av. run). 
 
Figure 3.3 - Calibration curve designed for all four quantification runs. 
In all calibration curves, was observed a linear regression with negative slope showing 
the existence of inverse proportionality between the CT values and the DNA 
concentration. All calibration curves, including the calibration curve for the set of the three 
runs (Av. run), were similar, substantially overlapping with each other with the exception 
of run 4 that although similar, was parallel to the others. All curves presented correlation 
coefficients (R2) higher than 0.99, demonstrating primer efficiency and showing the 
proximity between the regression line and the CT values for each standard. Thus, the 
consistency of results for the CT values of each of the analyzed standards, demonstrated 
the kit repeatability and reproducibility. 
3.2.3. Mixture studies 
The ability to quantify different concentrations of male and female DNA in mixtures was 
evaluated by the analysis of quantification results for each Male : Female (M:F) ratio. For 
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that, two samples - a female and a male sample - with known concentrations (5.68 ng/µL 
and 4.17 ng/µL, respectively) were selected. As the samples selected for preparing the 
mixtures contained different concentrations, were normalized to 0.5 ng/µL by diluting the 
initial extract with TE. Then, was performed the mixture of both samples to prepare seven 
solutions with different M:F ratios (Table 3.3). These seven solutions were manually 
prepared and distributed in quantification plate using the QIAgility™ robot. 
Table 3.3- Quantification results obtained for the different ratios M:F from prepared mixtures. 
M:F ratio obtained 
(ng/µL) 
Total DNA 
(ng/µL) 
Male DNA 
(ng/µL) 
Female DNA 
(ng/µL) 
M:F ratio obtained 
(ng/µL) 
19:1 0.182 0.175 0.006 25:1 
9:1 0.168 0.148 0.020 7.40:1 
3:1 0.188 0.128 0.060 2.13:1 
1:1 0.180 0.083 0.097 1:1.17 
1:3 0.215 0.051 0.163 1:3.13 
1:9 0.266 0.030 0.235 1:7.83 
1:19 0.227 0.014 0.213 1:15.21 
The concentration values of total DNA and male DNA resulted from the quantification 
results obtained for the short and Y targets, respectively. The concentration of female 
DNA is an approximate value, resulting from the subtraction of the Male DNA 
concentration to the total DNA concentration. 
The analysis of the quantification values present in Table 3.3 demonstrated that the 
values obtained for the quantification of total DNA were different from the expected 
theoretical concentrations of 0.5 ng/µL. However, it was possible to observe that the M:F 
ratios obtained were similar to the expected theoretical M:F ratios, suggesting variations 
during pipetting that can possibly had occurred during mixtures preparation. Analyzing 
the quantification values obtained for both male and female DNA, was possible to 
determinate the major and minor contributors for each sample, attesting the kit's ability 
to discriminate between two different contributors with different proportions. Thus, the 
results obtained for this parameter demonstrated the ability of the InnoQuant® HY kit to 
quantify different concentrations of male and female DNA, in mixtures with different M:F 
ratios. 
3.2.4. Concordance study 
A concordance study was performed to evaluate the performance of InnoQuant® HY kit 
in challenging samples in forensic analysis, when compared with the Quantifiler® Duo kit 
that is currently in use at the LPC-PJ. A total of 132 samples (including three control 
samples) was selected from existing extracts of the LPC-PJ casework, previously 
quantified with Quantifiler® Duo kit and amplified with GlobalFiler™ kit. This set of 
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samples presented quantification results non-concordant with the genetic profiles 
produced. The quantification results obtained with InnoQuant® HY kit and those 
previously obtained by Quantifiler® Duo are illustrated in Figure 3.4. 
 
Figure 3.4 - Percentage of quantified samples for each target of the InnoQuant® HY and Quantifiler® Duo kits (n=132). 
Among the 132 samples analyzed, three presented no quantification values for any of 
the kits tested. This indicates that these samples contained no DNA, possibly due to a 
less accomplished extraction. Also, approximately 96.2% and 93.2% (Short and Long 
targets, respectively) of the casework samples analyzed were successfully quantified 
with InnoQuant® HY kit. Regarding Quantifiler® Duo kit, approximately 64.4% of the 
samples presented quantification values. 
To make a comparison between the two kits, was necessary to note that the Quantifiler® 
Duo kit quantifies the total amount existing in the sample (Human target), which induces 
that the comparison should be made with the short target of InnoQuant® HY. However, 
the amplicon length quantified by Human and Short target is different (140 bp and 80bp, 
respectively), which could lead to doubts due to the quality of DNA present in the sample. 
Therefore, the comparison was performed between the Long target of InnoQuant® HY 
kit and the Human target of Quantifiler® Duo kit. Thus, the comparison between these 
two targets demonstrated that the InnoQuant® HY was able to produce quantification 
results in nearly 28.8% more of the analyzed samples than with the Quantifiler® Duo kit, 
indicating that the InnoQuant® HY was more effective in treating challenging samples. 
In addition to this ability to produce better results, InnoQuant® HY also allowed 
calculating the degradation index (DI) of samples, was absent in the kit used currently in 
LPC-PJ. This DI was determined by the ratio between the concentrations of long and 
short targets as presented in the following equation: 
Equation 3.1: 𝐃𝐈 =
[𝐒𝐡𝐨𝐫𝐭]
[𝐋𝐨𝐧𝐠]
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As mentioned above, the short target results represent the concentration of total DNA 
present in the sample, while the long target contribute to determining the degradation 
index. The first target to express changes when the sample is degraded is the long target 
due to the susceptibility conferred by its size. Therefore, using the calculated DI was 
possible observe that the samples analyzed possessed some level of degradation (Table 
3.4). 
Table 3.4– Degradation index in the set of analyzed samples. 
DI 
Number of 
Samples 
Percentage 
Number of Samples with 
QDuo values > 0.1 ng/uL 
Full 
Profile 
Percentage 
< 3 28 22.8 8 8 100 
3-5 33 26.8 1 0 0 
6-10 24 19.5 2 1 50 
11-15 6 4.9 0 0 0 
16-20 6 4.9 0 0 0 
21-30 9 7.3 0 0 0 
31-60 6 4.9 0 0 0 
> 60 11 8.9 0 0 0 
The results for this parameter indicated that 46.3% of the analyzed samples had a DI 
between 3 and 10, while 30.9% had DI values superior to 10. These values indicated 
that a significant percentage of the samples analyzed (77.2%) had moderate to high 
degradation. These high sample degradation values can cause problems in assessing 
the amount of DNA input for amplification which may lead to subsequent rework. Of the 
28 samples that had an index of degradation lower than three, only 13 had a degradation 
index of 1 (not degraded). These samples were distributed among sub groups II, III, IV 
and VI (inconclusive, complete, IPC+, and inhibited DNA, respectively). 
Thus, this new tool provided by the InnoQuant® HY allowed a prior knowledge about the 
DNA quality present in the samples and, therefore, to determine the best strategy to be 
adopted for the production of results, minimizing unnecessary re-amplifications. 
3.3. Internal Validation of InnoTyper® 21 kit 
Determining the genetic profile of an individual in a given sample is the purpose of 
forensic genetics, whether in a criminal investigation or missing person identification. For 
this, amplification methods of the DNA extracted from these samples is a crucial step 
and as such, the most important. As the DNA from forensic samples typically has low 
quality and quantity, there arises the need to implement an amplification method which 
overcomes these problems and permits obtaining genetic profiles in this type of samples. 
Thus, the development of a kit with the ability to amplify fragments as small as 125 bp 
becomes an advantage for forensic laboratories.  
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The internal validation of the InnoTyper® 21 kit in LPC-PJ to enable its subsequent 
implementation in the laboratory routine for the analysis of this type of challenging 
samples was the main objective of this work, and for that, sensitivity, repeatability and 
reproducibility tests were performed. 
3.3.1. Sensitivity 
The optimal DNA template target for the InnoTyper® 21 kit is between 0.2 – 0.5 ng/µL. 
Thus, to study the sensitivity of this kit were prepared five Positive Controls (PC1 to PC5) 
from InnoTyper® 21 DNA Control with different concentrations ranging from 0.6 ng/µL to 
0.12 ng/µL. All solutions were prepared and amplified according to manufacturer’s 
instructions and applied in duplicate. The results of amplification obtained through 
capillary electrophoresis are described in Table 3.5. The aim of this study was to evaluate 
the kit capacity to produce good quality genetic profiles outside their optimal range of 
operation. 
Table 3.5 – Number of amplified alleles and respective percentage for each of the Positive Controls analyzed. 
Samples 
Concentration 
(ng/µL) 
number of alleles obtained Percentage (%) 
1st repetition 2nd repetition 1st repetition 2nd repetition 
PC1 0.12 34 28 80.95 66.67 
PC2 0.24 40 40 95.24 95.24 
PC3 0.36 40 41 95.24 97.62 
PC4 0.48 42 41 100 97.62 
PC5 0.60 42 42 100 100 
NTC 0 0 0 0 0 
The kit was able to amplify DNA quantities above and below the optimal DNA template 
target range. However, when the DNA concentration was below the minimum limit of 
optimal DNA input, the percentage of amplified alleles was considerably reduced. Also, 
it was possible to observe a small difference between the first and the second repetition 
performed (p > 0.05). However, this difference did not compromise the results (Appendix 
VII). Concerning the concentrations within optimal amplification range, the results were 
not in accordance with the expected since complete profiles were not obtained. However, 
the number of amplified alleles was similar to the entire profile, and an amplification 
failure of the same marker in the Positive Controls 2, 3 and 4 was observed. These small 
discrepancies observed may be related to amplification problems. 
In general, the results obtained from the analysis of this parameter allowed to confirm 
the sensitivity of the InnoTyper® 21 kit, either to amplify samples with low concentrations 
or with concentrations above the optimal amplification range. 
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3.3.2. Repeatability and Reproducibility 
For the study of repeatability and reproducibility was proceeded to the analysis of genetic 
profiles obtained for the five Positive Controls (PC1 to PC5) used for the sensitivity test, 
performed in duplicate and run with three different injection times: 16 seconds, 18 
seconds (default), and 20 seconds. The percentage of amplified alleles in each positive 
control is illustrated in Figure 3.5 (Appendix VIII). 
 
Figure 3.5 - Percentage of amplified alleles for each Positive Control run in replicates with three different injection times. 
Data are mean ± stdev of two experiments. 
Through individual assessment of each capillary electrophoresis run with the different 
injection times, was possible to observe that the percentage of amplified alleles for each 
control was similar among duplicates. Also, it was possible to observe a large percentage 
of amplified alleles for all the controls (superior to 94%) except for the PC1 whose 
percentage of amplified fragments was expressively lower (between 64% and 74%) 
when compared with the others, however not significant (p > 0.05) (Appendix VIII). This 
discrepancy may be related to the low concentration of DNA existing in this sample. The 
analysis of Figure 3.5 also allowed observing that no significant differences were 
detected between the different runs performed, except in the second repetition, where 
there was a decrease, although not significant (p < 0.05), in the number of amplified 
fragments that was constant in all the controls and runs (Appendix VIII). The quality of 
the amplification results can also be related to the fact that the reagents were not properly 
mixed, yielding lower peak height when compared with in-house manufacturer’s results 
(Figure 3.6). 
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Figure 3.6 - Peak heights average, in RFU, for each of the controls analyzed and Allelic ladder. 
Overall, in the three runs performed, the percentage of amplified alleles for each of the 
five controls was similar. Thus, from the genetic profiles obtained for these two 
parameters, was possible prove the repeatability of InnoTyper® 21 kit, as well as its 
reproducibility, allowing to internally validate this new amplification kit. 
3.3.3. Concordance Study 
As described for quantification kit, this study was performed to evaluate the performance 
of InnoTyper® 21 kit in challenging samples for forensic analysis, comparing this new kit 
with GlobalFiler™, the kit currently in use at the LPC-PJ. Therefore, from the 132 
samples previously quantified with the InnoQuant® HY kit, 127 were selected for 
subsequent amplification with the InnoTyper® 21 kit, using a DNA input of 0.5 ng/µL. The 
results obtained by InnoTyper® 21 kit, as well as the results obtained by GlobalFiler™ kit 
are illustrated Figure3.7. 
 
Figure 3.7 - Amplified alleles from the samples analyzed with InnoTyper® 21 and GlobalFiler™ kits (n=127). 
The comparison between the results obtained by the two kits demonstrated that both 
presented difficulties in the amplification of the samples selected, and with this new 
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amplification kit nearly 9% more samples without results were obtained. Although 
InnoTyper® 21 kit produced more complete genetic profiles (27 vs. 21 obtained by 
GlobalFiler™), overall, the GlobalFiler™ kit originated approximately 2% more genetic 
profiles with the highest number of amplified alleles. However, it should be noted that the 
amplification with the GlobalFiler™ kit was performed with fresh extracts, whereas when 
it proceeded to amplification with InnoTyper® 21 kit, the selected extracts were subjected 
to thawing and, in some cases, the samples had already undergone at least one thawing 
and refreezing process before being used by InnoTyper® 21 kit. Therefore, this defrosting 
and refreezing of samples and the use of samples extracted by another method than the 
recommended by the manufacturer can be the determining factor in explaining the 
difference between the two kits compared in this study. 
Overall, the results demonstrated that for challenging samples and under the conditions 
used in this study, the differences observed between the two kits were not significant. 
Therefore, the utility of InnoTyper® 21 has been proven, especially by the successful 
amplification of a greater number of complete genetic profiles. 
3.4. Evaluation of InnoQuant® HY and InnoTyper® 21 kits for 
DNA analysis of rootless hair 
One of the main goals of the development of these two retrotransposons-based kits was, 
somehow, to facilitate the forensic analysis of challenging samples with a limited number 
of complete genetic profiles. Therefore, in this study, challenging samples collected from 
real crime scenes were used to evaluate the performance of InnoQuant® HY and 
InnoTyper® 21 kits. A set of 40 strands of hair received from different crime scenes, were 
analyzed under the microscope for the detection and removal of the root. The processed 
hair fragments were subjected to several washes and subsequently to DNA extraction 
using the extraction method mentioned above. The obtained DNA extracts were 
quantified with InnoQuant® HY kit (only was possible to quantify 17 from the 40 samples, 
due to kit lack), and sample degradation index was calculated. Finally, the amplification 
of theses DNA extracts (DNA input of 0.5 ng/µL) with InnoTyper® 21 kit was performed. 
This set of samples was amplified with the GlobalFiler™ kit, to compare the two kits 
accurately. The quantification results, as well as the degradation index for the 17 
samples analyzed with InnoQuant® HY kit are presented in Table 3.6. 
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Table 3.6– Quantification results obtained for Short, Long and Y targets and respective degradation index (n=17). 
Sample  Short (ng/µL) Long (ng/µL) Y (ng/µL) Degradation Index 
14 0.000041 0.000004 - 9.44 
15 0.000026 0.000001 - 22.65 
16 0.000030 0.000001 - 42.35 
17 0.000100 0.000017 0.000009 5.81 
18 0.000020 0.000000 - 81.32 
19 0.000021 0.000001 - 17.73 
20 0.000020 0.000002 0.000011 9.13 
21 0.000013 0.000001 - 15.04 
22 0.000014 0.000001 - 13.95 
23 0.000017 0.000001 - 12.20 
24 0.000015 0.000000 - 29.77 
25 0.000014 - - Undetermined 
26 0.000021 0.000000 - 83.01 
27 0.000024 0.000001 - 46.25 
28 0.000149 0.000012 - 12.27 
29 0.000043 0.000003 - 16.81 
30 0.000189 0.000013 - 14.70 
All the tested samples presented degradation. Among these samples, 17.65% had 
moderate degradation, while 76.47% presented a very high degradation rate. For one of 
the analyzed samples (sample 25), the InnoQuant® HY kit was unable to quantify the 
long target, indicating that the existing DNA was fully degraded to fragments smaller than 
125 bp. These results allowed to determine the best amplification method to used, since 
the probability of obtaining results with this type of samples will be quite difficult due the 
highly fragmentation of the DNA. 
Based on the quantitation results, these samples were amplified with InnoTyper® 21 and 
GlobalFiler™ kits, taking into account the DNA input required. The percentages of the 
amplified alleles for both kits are illustrated in Figure 3.8. 
 
Figure 3.8 - Percentages of amplified alleles for InnoTyper® 21 and GlobalFiler™ kits (n= 40). 
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The analysis of the genetic profiles obtained for each amplification kit allowed to verify 
that the InnoTyper® 21 kit was able to amplify fragments in the 40 samples while the 
GlobalFiler™ kit only produced results in two samples. Also, it was possible to observe 
that in nearly 23% of the samples, the retrotransposon-based kit presented genetic 
profiles with quality to be reported (Appendix IX), of which 10% presented complete 
genetic profiles (Appendix XI). It was also possible to observe that 18% of the samples 
presented between 30 to 59% of amplified alleles in their genetic profile. Thus, the 
comparison between the results produced by both kits demonstrated that the InnoTyper® 
21 kit produced better results than GlobalFiler™ kit when operated in fresh extracts with 
a modified extraction method. Additionally, it was possible to find that many of the 
samples exhibited amplification peaks in genetic profile (nearly 60%). However, these 
samples did not have quality to be reported since due to the reduced RFU peak size 
(Appendix XI). As was already verified during the internal validation of this new kit, the 
peak heights were lower indicating that the reagents necessary for amplification were 
not be properly mixed by the robot used for sample preparation. 
In general, the results obtained for rootless hair samples allowed to confirm that both 
InnoQuant® HY and InnoTyper® 21 kits represent very good alternatives for the analysis 
of challenging samples frequently received in forensic laboratories. These results also 
demonstrated the importance of having knowledge on the quality of DNA present in a 
given sample, because a high degradation rate leaded to a decreased quality of the 
genetic profiles. Thus, the InnoQuant® HY can be used to predict a particular genetic 
profile (via DI) and, thus, to determine the quantity of DNA input to be added to the 
amplification reaction to overcome the degradation effect and obtain better results.  
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4. Conclusion 
Obtaining a genetic profile from pieces of evidence collected at a crime scene is the 
primary objective of forensic laboratories. However, most samples sent for forensic 
laboratories do not present good DNA quality and/or quantity to be amplified. In this 
sense, the quantification of the samples is crucial in the forensic analysis since it allows 
knowing the amount of DNA available in a given sample and thus, determining the better 
amplification method. 
The present study aimed to evaluate and internally validate two new retrotransposons-
based kits, InnoQuant® HY and InnoTyper® 21, for its later implementation in the routine 
laboratory of the Laboratório de Polícia Científica da Polícia Judiciária to analyze 
challenging samples. 
To internally validate both InnoQuant® HY and InnoTyper® 21 kits the following 
parameters were studied: sensitivity, repeatability and reproducibility, mixtures (only for 
the InnoQuant® HY kit), and concordance. Additionally, the functionality of both kits for 
results production in rootless hair samples was also evaluated. 
The sensitivity of the InnoQuant® HY kit was assessed using a serial dilution with six 
different concentrations, as well as an intermediate dilution. The results obtained 
confirmed the sensitivity of the kit in the quantification of high DNA concentrations, as 
well as in the quantification of very low concentrations of DNA, even revealing that the 
concentrations obtained for the serial dilutions were similar to the expected theoretical 
concentrations. The sensitivity of the InnoTyper® 21 kit was evaluated using five Positive 
Controls with DNA concentration values higher and lower the optimal DNA template 
target range. The results obtained proven the sensitivity of the InnoTyper® 21 kit to 
amplify samples with concentrations higher and lower their optimal amplification range. 
In the repeatability and reproducibility studies were evaluated the five standards used to 
obtain a calibration curve to InnoQuant® HY kit and the five Positive Controls for 
InnoTyper® 21 kit. The consistency of results for the CT values of each of the analyzed 
standards in the four quantification runs performed, proved the InnoQuant® HY kit 
repeatability and reproducibility. For InnoTyper® 21 kit, the percentage of amplified 
alleles for each control conducted in both repetitions was similar to each other as well as 
along the three different runs performed, proving the kit repeatability and reproducibility. 
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Regarding the mixtures study, performed only for quantification kit, was observed that 
the InnoQuant® HY kit was able to determine different concentrations of male DNA 
versus female DNA in mixtures with different ratios M:F, and so determinate the major 
and minor contributors in each sample. These results attested the kit ability to 
discriminate between two different contributors with different proportions. 
Even within the internal validation, were performed concordance studies between 
InnoQuant® HY and InnoTyper® 21 kits and kits currently in use at the LPC-PJ - 
Quantifiler® Duo and GlobalFiler™, respectively. The results obtained allowed to 
determine that InnoQuant® HY had the ability to produce quantification results in 29% 
more of the analyzed samples than the Quantifiler® Duo kit, making the InnoQuant® HY 
kit more efficient in the analysis of challenging samples. Additionally, the InnoQuant® HY 
kit also allowed to calculate sample degradation index (DI), the missing tool in the kit 
used currently in LPC-PJ, allowing a better approach during the amplification step. 
Comparison the results obtained with both amplification kits, it was demonstrate that in 
casework samples with freezing and thawing cycles, the differences observed between 
them were not significant. However, it can be hypothesized that the fact that the 
InnoTyper® 21 kit was operated with extracts subjected to these conditions may have 
impaired the results produced by this kit since the results produced by GlobalFiler™ were 
obtained from fresh extracts. 
Thus, the results obtained internally validated both InnoQuant® HY and InnoTyper® 21 
kits, allowing its implementation in the routine laboratory at the LPC-PJ for the treatment 
of challenging samples. 
Finally, the evaluation of the functionality of both InnoQuant® HY and InnoTyper® 21 kits 
was performed in rootless hair samples, collected from real crime scenes. The results 
demonstrated that InnoQuant® HY kit was able to determine the concentration of DNA 
present in each sample as well as its degradation index. Among these samples, 17.65% 
presented moderate degradation while 76.47% exhibited a very high degradation rate. 
Through these results, it will be possible for a forensic expert to select the best 
amplification method to apply and the DNA input to be added to the amplification 
reaction. Thus, in samples with higher DNA concentration was possible to obtain a more 
complete genetic profile. The analysis of the genetic profiles obtained allowed verifying 
that the InnoTyper® 21 kit was able to amplify fragments in all the analyzed samples, 
with nearly 23% of these samples producing genetic profiles with quality to be reported, 
of which 10% presented complete genetic profiles (Appendix IX). Also, it was observed 
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that the amplification of these samples with the GlobalFiler™ kit failed, allowing to 
demonstrate that the InnoTyper® 21 kit was most efficient when operated with freshly 
obtained extracts. 
In general, these results proved that both InnoQuant® HY and InnoTyper® 21 kits 
represent very good alternatives for the analysis of challenging samples, which are the 
most commonly received in forensic laboratories. 
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Appendix I – InnoTyper® 21 marker Information: loci amplified and the corresponding 
fluorescent marker dyes, observed allele sizes (in base pairs) and the genotype of the 
DNA Positive Control 
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Appendix II – Equipment from LPC-PJ used in this study 
Figure 1 - AutoMate™ Express Instrument 
and laminar flow camera with pipes support on 
inside 
Figure 2 – ABI 7500 HID Real-Time 
PCR analysis 
Figure 3 – Thermal cycler GeneAmp® PCR 
System 9700 with gold-plated silver 96-Well 
Block equipment  
Figure 4 – ABI 3130XL Genetic 
Analyzer equipment 
Figure 5 – QIAgility™ robot present in pre-
PCR room used to prepare the plates for DNA 
quantification 
Figure 6 – QIAgility™ robot present 
in post-PCR room used to prepare 
the plates for the capillary 
electrophoresis 
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Appendix III – Retrotransposons-based kits used in the present study 
Figure 1 - InnoQuant® HY kit Figure 2 - InnoQuant® HY Spectral 
Calibration kit 
Figure 3 - InnoTyper® 21 kit Figure 4 – IGT 5 Dye Matrix 
Standard kit 
 
Figure 5 – ILS- Internal Line Standard and Allelic ladder 
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Appendix IV - Selected samples and their division according to the genetic profile 
presented 
Group Sample Ext Trace Quantification value (QD) Type of profile 
I 
1 430-11 Hair ------------ 
No Results 
2 442-02 Hair ------------ 
3 442-07 Hair ------------ 
4 430-02 Hair ------------ 
5 447-02 Hair ------------ 
6 447-12 Hair ------------ 
7 447-04 Hair ------------ 
8 450-01 Hair ------------ 
9 450-04 Hair ------------ 
10 450-05 Hair ------------ 
11 450-06 Hair ------------ 
12 450-07 Hair ------------ 
13 450-11 Hair ------------ 
14 450-12 Hair ------------ 
15 442-06 Hair 0.001 
16 430-07 Hair ------------ 
17 442-10 Hair 0.001 
18 442-05 Hair 0.002 
19 103-10 Hair ------------ 
20 154-12 Hair ------------ 
21 257-05 Hair ------------ 
22 310-13 Hair ------------ 
23 386-06 Hair ------------ 
24 033-10 Hair ------------ 
25 245-06 Hair ------------ 
26 266-02 Hair 0.000 
27 266-07 Hair 0.000 
28 266-04 Hair 0.000 
29 033-04 Hair 0.001 
30 266-01 Hair 0.001 
31 295-11 Hair 0.001 
32 317-07 Hair 0.001 
33 033-05 Hair 0.002 
34 033-12 Hair 0.002 
35 245-05 Hair 0.002 
36 033-06 Hair 0.003 
37 245-04 Hair 0.003 
38 266-06 Hair 0.003 
39 081-09 Hair 0.006 
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Group Sample Ext Trace Quantification value (QD) Type of profile 
II 
40 442-01 Hair ------- 
Inconclusive 
41 450-02 Hair ------- 
42 358-03 Hair 0.003 
43 442-04 Hair -------- 
44 430-12 Hair 0.002 
45 447-03 Hair 0.003 
46 447-09 Hair 0.023 
47 317-01 Hair ------- 
48 317-04 Hair ------- 
49 015-11 Hair ------- 
50 046-06 Hair -------- 
51 155-08 Hair 0.003 
52 358-04 Hair --------- 
53 348-08 Hair --------- 
54 348-07 Hair 0.003 
55 310-06 Hair 0.009 
III 
56 430-04 Hair 0.001 
Complete 
57 447-08 Hair 0.024 
58 442-09 Hair 0.087 
59 430-03 Hair 0.435 
60 295-09 Hair 0.021 
61 295-10 Hair 0.531 
62 151-01 Hair 1.316 
63 033-09 Hair 1.587 
IV
 
IP
C
 +
 
64 452-12 Biologic --------- No Results 
65 454-06 Biologic --------- No Results 
66 454-06 Biologic --------- No Results 
67 452-11 Biologic --------- 
Mixture (only 
quantification) 
68 452-09 Biologic 0.012 
Mixture (only 
quantification) 
69 109-05 Hair 0.002 No Results 
70 109-09 Hair 1.201 Complete 
71 109-10 Hair 0.610 Complete 
72 103-13 Hair --------- No Results 
73 263-03 Biologic 0.002 Inconclusive 
74 134-12 Biologic 0.049 Inconclusive 
75 129-01 Semen 0.016 Inconclusive 
76 097-10 Semen 0.003 Inconclusive 
77 096-10 Semen 0.004 No Results 
78 097-11 Semen 0.015 Complete 
  79 297-04 Biologic --------- No Results 
  80 297-05 Biologic 0.001 No Results 
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Group Sample Ext Trace Quantification value (QD) Type of profile 
IV
 
IP
C
 +
 
81 297-03 Biologic -------- No Results 
82 134-05 Biologic 0.088 Complete 
83 134-06 Biologic 0.007 Inconclusive 
84 297-10 Biologic 0.005 No Results 
85 134-04 Biologic 0.009 Inconclusive 
86 134-11 Biologic 0.012 Inconclusive 
V
 
D
e
g
ra
d
e
d
 D
N
A
 
87 465-02 AR 0.006 
Inconclusive 
88 457-17 AR 0.006 
89 457-03 AR 0.010 
90 447-05 Hair 0.011 
91 375-24 AR 0.012 
92 457-02 AR 0.016 
93 457-11 AR 0.021 
94 457-01 AR 0.041 
95 457-16 AR 0.053 
96 457-07 AR 0.060 
97 401-15 AR 0.078 
98 457-21 AR 0.099 
99 447-10 Hair 0.111 
100 465-01 AR 0.265 
101 455-04 Biologic 0.052 
102 423-01 Biologic 0.002 
103 462-11 Biologic 0.004 
104 033-08 Hair 0.012 
105 151-04 Hair 0.001 
106 310-07 Hair 0.054 
107 435-11 Hair 0.011 
108 368-01 Hair 0.000 
109 369-02 Biologic 0.004 
110 369-04 Biologic 0.004 
111 380-04 RBC --------- 
112 381-03 Biologic 0.003 
113 381-07 Biologic 0.007 
114 418-02 Biologic 0.007 
115 423-09 Biologic 0.024 
116 370-05 ---------  0.012 
117 151-07 Hair 0.006 
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Group Sample Ext Trace Quantification value (QD) Type of profile 
V
I 
D
e
g
ra
d
e
d
 o
r 
in
h
ib
it
e
d
 D
N
A
 
118 101-01 Teeth ------- No Results 
119 113-02 Teeth -------- No Results 
120 113-01 Teeth 0.001 No Results 
121 113-03 Teeth 0.26 Complete 
122 452-04 RBC 1.092 Inconclusive 
123 126-04 Teeth 0.008 Inconclusive 
124 122-03 Teeth -------- No Results 
125 054-05 Teeth 1.275 Inconclusive 
126 106-02 Teeth ------- Inconclusive 
127 122-06 Teeth -------- No Results 
128 432-02 Teeth 0.001 Inconclusive 
129 432-03 Teeth -------- Inconclusive 
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Appendix V - Quantification results, respective averages and standard deviation for the 
targets Short, Long and Y analyzed by InnoQuant® HY kit in the sensitivity test 
 
 
1st Rep 2nd Rep Average Desviation
Intermediate Dilution 10 13.07 11.29 12.18 1.26 -
Dilution 1 1 1.10 1.13 1.12 0.03 0.9
Dilution 2 0.5 0.68 0.60 0.64 0.05 0.46
Dilution 3 0.250 0.284 0.299 0.292 0.01 0.215
Dilution 4 0.125 0.143 0.141 0.142 0.001 0.124
Dilution 5 0.063 0.064 0.071 0.068 0.005 0.056
Dilution 6 0.031 0.034 0.038 0.036 0.003 0.033
NS
0.064
Intermediate Dilution 10 10.25 5.67 7.96 3.24 -
Dilution 1 1 1.07 1,03 1.05 0.03 0.83
Dilution 2 0.5 0.64 0.57 0.60 0.05 0.47
Dilution 3 0.250 0.270 0.298 0.284 0.02 0.183
Dilution 4 0.125 0.159 0.156 0.158 0.002 0.109
Dilution 5 0.063 0.069 0.088 0.079 0.013 0.070
Dilution 6 0.031 0.032 0.034 0.033 0.001 0.026
NS
0.054
Intermediate Dilution 10 9.19 11.85 10.52 1.88 -
Dilution 1 1 1.08 1.19 1.13 0.08 0.88
Dilution 2 0.5 0.69 0.60 0.64 0.06 0.294
Dilution 3 0.250 0.299 0.297 0.298 0.001 0.161
Dilution 4 0.125 0.138 0.152 0.145 0.01 0.103
Dilution 5 0.063 0.067 0.065 0.066 0.001 0.071
Dilution 6 0.031 0.032 0.031 0.0315 0.0007 0.018
NS
0.064
L
o
n
g
Y
Observed values 
(ng/µL) - Manual
S
h
o
rt
Target Expected Values (ng/µL)
Observed values (ng/µL) - QIAgility™ 
robot
Significance
Pvalue
Significance
Pvalue
Significance
Pvalue
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Annex VI - CT values, respective averages and standard deviation for all the four targets analyzed by InnoQuant® HY kit in the four runs performed 
to repeatability and reproducibility tests 
 
Note: Global Average represents the average from the four runs. Standard error corresponds to the standard deviation amongst the four runs. For the 
comparison within runs, a Chi-square test was performed. 
 
CT1 CT2 Average Desviation CT3 CT4 Average Desviation CT5 CT6 Average Desviation CT7 CT8 Average Desviation
Std 1 20 11.23 11.27 11.25 0.03 11.27 10.99 11.13 0.20 11.08 11.24 11.16 0.11 13.81 12.1 12.96 1.21 11.62 0.47
Std 2 2.5 14.10 14.12 14.11 0.01 14.20 14.03 14.12 0.12 13.96 14.1 14.03 0.10 15.93 16.23 16.08 0.21 14.58 0.46
Std 3 0.3125 17.03 16.96 17.00 0.05 17.04 17.07 17.06 0.02 16.82 16.92 16.87 0.07 18.91 18.85 18.88 0.04 17.45 0.44
Std 4 0.0391 20.03 19.96 20.00 0.05 20.11 19.94 20.03 0.12 19.98 19.98 19.98 0.00 22.11 22.24 22.18 0.09 20.54 0.50
Std 5 0.005 22.79 22.88 22.84 0.06 22.84 24.74 23.79 1.34 22.68 22.77 22.73 0.06 25.7 26.3 26.00 0.42 23.84 0.75
NS NS NS NS NS
0.074 0.150 0 .363 0 .146 0.057
Std 1 20 14.86 15.04 14.95 0.13 15.31 14.95 15.13 0.25 14.95 15.07 15.01 0.09 11.65 11.16 11.40 0.34 14.12 0.84
Std 2 2.5 17.71 17.61 17.66 0.07 17.64 17.48 17.56 0.11 17.57 17.70 17.64 0.10 14.13 15.02 14.57 0.63 16.86 0.72
Std 3 0.3125 20.67 20.79 20.73 0.09 20.74 20.74 20.74 0.00 20.55 20.51 20.53 0.03 17.39 17.61 17.50 0.15 19.88 0.74
Std 4 0.0391 23.70 23.49 23.60 0.15 23.74 23.60 23.67 0.10 23.56 23.45 23.50 0.08 20.65 20.93 20.79 0.19 22.89 0.65
Std 5 0.005 26.56 26.36 26.46 0.14 26.43 28.64 27.53 1.57 26.43 26.34 26.39 0.06 23.99 24.03 24.01 0.03 26.10 0.75
NS NS NS NS NS
0.153 0.317 0.173 0.219 0.178
Std 1 20 20.07 20.10 20.08 0.02 20.03 20.10 20.06 0.05 19.83 20.02 19.92 0.13 18.69 18.83 18.76 0.10 19.71 0.30
Std 2 2.5 22.92 22.86 22.89 0.05 22.88 22.78 22.83 0.08 22.79 22.70 22.74 0.06 21.50 20.37 20.93 0.80 22.35 0.46
Std 3 0.3125 25.70 25.60 25.65 0.07 25.50 25.62 25.56 0.08 25.48 25.53 25.51 0.04 23.89 25.18 24.54 0.91 25.31 0.30
Std 4 0.0391 28.51 28.82 28.66 0.23 28.59 28.42 28.51 0.12 28.47 28.58 28.53 0.07 27.62 28.09 27.85 0.33 28.39 0.19
Std 5 0.005 31.68 31.65 31.66 0.02 31.51 32.66 32.08 0.81 31.17 31.67 31.42 0.35 30.64 31.38 31.01 0.53 31.54 0.29
NS NS NS NS NS
0.452 0.470 0.415 0.084 0.066
Std 1 20 21.11 20.92 21.02 0.14 21.01 20.98 21.00 0.02 21.07 20.99 21.03 0.06 17.47 17.41 14.95 0.13 19.50 0.83
Std 2 2.5 20.19 19.75 19.97 0.31 20.15 19.69 19.92 0.32 20.16 19.79 19.97 0.26 17.86 17.75 17.66 0,07 19.38 0.51
Std 3 0.3125 19.98 19.93 19.95 0.03 19.87 19.89 19.88 0.01 19.86 19.82 19.84 0.03 18.43 18.42 20.73 0,09 20.10 0.34
Std 4 0.0391 20.53 20.55 20.54 0.02 20.53 20.57 20.55 0.03 20.44 20.50 20.47 0.04 19.18 19.72 23.60 0,15 21.29 0.26
Std 5 0.005 21.06 21.12 21.09 0.04 20.88 21.07 20.97 0.13 21.04 20.92 20.98 0.08 19.54 19.71 26.46 0,14 22.38 0.33
NS NS * NS NS
0.160 0.304 0.042 0.315 0.997
Global 
Average
Standard 
error
Y
Significance
Pvalue
IP
C
Significance
Pvalue
Run 4
S
h
o
rt
Standard
Concentration 
(ng/µL)
L
o
n
g
 
Significance
Pvalue
Significance
Pvalue
Target
Run 1 Run 2 Run 3
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Annex VII- Number of amplified alleles, respective averages and standard deviation 
obtained by InnoTyper® 21 kit in the sensitivity test 
 
1st Rep 2nd Rep Average Stdev 1st Rep 2nd Rep Average Stdev
PC1 0.12 34 28 31 4.24 80.95 66.67 73.81 10.10
PC2 0.24 40 40 40 0 95.24 95.24 95.24 0
PC3 0.36 40 41 40.5 0.71 95.24 97.62 96.43 1.68
PC4 0.48 42 41 41.5 0.71 100 97.62 98.81 1.68
PC5 0.6 42 42 42 0 100 100 100 0
NS NS
0.459 0.474Pvalue
Number of alleles obtained Percentage (%)Concentration 
(ng/µL)
Samples
Significance
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Annex VIII - Number of amplified alleles, respective averages and standard deviation 
obtained for each positive control tested by InnoTyper® 21 kit with different injection times 
to test repeatability and reproducibility 
 
Note: For the comparison within runs, a Chi-square test was performed. 
  
PC1 PC2 PC3 PC4 PC5
0.12 0.24 0.36 0.48 0.6
1st rep 28 39 39 42 42
2nd rep 25 40 40 40 42
Average 26,5 39,5 39,5 41 42
Stdev 2.12 0.71 0.71 1.41 0
1st rep 67 93 93 100 100
2nd rep 60 95 95 95 100
Average 63,5 94 94 97,5 100
Stdev 2.45 0.71 0.71 1.77 0
1st rep 28 39 40 42 42
2nd rep 24 40 40 40 42
Average 26 39,5 40 41 42
Stdev 1.41 0.35 0 0.71 0
1st rep 67 93 95 100 100
2nd rep 57 95 95 95 100
Average 62 94 95 97.5 100
Stdev 3.54 0.71 0 1.77 0
1st rep 34 40 40 42 42
2nd rep 28 40 41 41 42
Average 31 40 40,5 41,5 42
Stdev 2.12 0 0.35 0.35 0
1st rep 81 95 95 100 100
2nd rep 67 95 98 98 100
Average 74 95 96,5 99 100
Stdev 4.95 0 1.06 0.71 0
%
Sample
Concentration (ng/µL)
0.436
0.409
0.401
0.35
0.362
Number 
of Alleles
%
T
im
e
 I
n
je
c
ti
o
n
NS
NS
NS
NS
NS
NS
Number 
of Alleles
%
Number 
of Alleles
2
0
 s
e
c
o
n
d
s
1
8
 s
e
c
o
n
d
s
Significance Pvalue
1
6
 s
e
c
o
n
d
s 0.443
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Annex IX – Example of a genetic profile with quality to be reported 
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Annex X – Example of a complete genetic profile  
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Annex XI – Example of a genetic profile exhibiting amplification peaks which could not 
be reported since due to the reduced RFU peak size 
 
 
